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Abstract 
Activation of the intrinsic pathway of apoptosis is related to the permeabilization 
of mitochondrial membranes. This complex process is far away from being 
completely understood but, generally, could be divided into two steps that, 
depending on the experimental conditions, can be linked or independent: the 
permeabilization of the mitochondrial outer membrane and the opening of the 
mitochondrial permeability transition pore. Both processes are tightly regulated by 
different components that attract increasing interest as promising targets for 
several diseases treatment, in particular cancer. A large number of mitochondrial 
permeability transition pore-targeting agents, indeed, are under studies because 
the mitochondrial apoptotic machinery in cancer cells is structurally and 
functionally different from that of normal cells. Thus, mitochondrial-targeting 
agents are expected to have a tumor selectivity. 
In this scenario, a family of compounds known as biologically active amines 
acquires increasing importance. These amines, among which the most-known 
spermine, spermidine, putrescine and agmatine, are polycationic molecules at 
physiological pH, naturally present in almost all living species where they exert an 
essential role for cell growth and differentiation. It is to note that the polyamine 
biosynthetic pathway is very active in cancer cells and that high polyamines 
concentrations are often present in rapidly dividing tumor cells and growing 
tissues. Moreover the deregulation of polyamine metabolism may induce 
apoptosis. Thus, their primary role in regulating proliferation and cell death led 
scientists to investigate their role at a mitochondrial level. The main target of 
these amines seems to be the mitochondrial permeability transition: spermine, 
spermidine and putrescine share an inhibitory action whereas agmatine acts (in 
liver) as an inducer or an inhibitor, depending on the concentrations used. 
Furthermore in mitochondria two specific mitochondrial transporters have been 
detected: one for spermine, spermidine, and putrescine and one for agmatine.  
 
The aim of this work is to study the action of biologically active amines as 
regulators of mitochondrial membrane permeabilization and pro-apoptotic factors 
release in isolated rat liver mitochondria. In particular their interaction with 
specific membrane structures is analyzed, trying to elucidate their mechanism of 
action. 
The first part of the work evidences the agmatine double effect on the 
permeability transition process. In particular the attention is focused on agmatine 
inhibiting action. Despite its protective effect on the mitochondrial permeability 
transition, the amine is able to induce the release of some pro-apoptotic factors. 
A possible explanation relates to the induction of the mitochondrial outer 
membrane permeabilization.  
A further confirmation of this proposal is obtained in the second part, by a 
comparison between agmatine and its analogue alpha-methyl-agmatine, a more 
powerful inhibitor of the mitochondrial permeability transition. The use of this 
compound allows to exclude that the production of hydrogen peroxide exhibited 
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by agmatine is one of the main causes of the mitochondrial outer membrane 
permeabilization observed. 
 
In the third part, the effect of the polyamines (in particular spermine and 
spermidine) on the permeabilization on mitochondrial membranes and on the 
release of pro-apoptotic factors is reported. Despite their well-known protective 
action against the opening of the pore, spermine and spermidine share with 
agmatine a similar behavior in inducing the release of some pro-apoptotic factors, 
even through different pathways. Thus, their mechanism of action is investigated, 
trying to evidence the specific membrane components involved. 
 
Finally, in the fourth part, an investigation about the mechanism of efflux of 
spermine is shown, focusing on the possibility that it could be linked with the 
efflux of ATP and phosphate, most likely in an electroneutral fashion. This 
observation is supported by the use of specific inhibitors of the adenine 
nucleotide translocator and phosphate carrier. 
 
In conclusion, the results obtained in this study first of all support the hypothesis 
that the permeabilization of the inner and outer membranes could be viewed as 
two distinct processes, even if often linked between them. Furthermore it is 
possible to state that the mitochondrial outer membrane permeabilization could 
be a contact point between intrinsic and extrinsic apoptosis, being induced both 
by intra- and extra-mitochondrial signals. It is already reported that the release of 
cytochrome c from mitochondria does not always result in apoptosis induction. In 
particular the redox state of the protein is crucial for the subsequent cascade of 
events: only oxidated cytochrome c is able to trigger apoptosis. For this reason, it 
is reasonable to think that the release of cytochrome c induced by biologically 
active amines could represent a starting point, but not a point of no return. In this 
context polyamines represent a useful tool to study both the mitochondrial outer 
membrane permeabilization and the mitochondrial permeability transition, trying 
to delineate structural and functional features. Moreover, in living cells 
polyamines are able to prevent or induce apoptosis, and the latter effect is 
caused by their metabolization by amine oxidases, with the production of 
cytotoxic metabolites. This dichotomic action depends on polyamines 
concentration, that is modulated, as supported by our data, also by mitochondrial 
polyamine cycling. More study is required to detect all structural mechanism 
involved in their cycling but, at least for spermine, a possible pathway of efflux is 
detected.  
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Sommario 
L'attivazione dell’apoptosi intrinseca è correlata alla permeabilizzazione delle 
membrane mitocondriali. Questo complicato processo, sebbene non sia stato 
ancora completamente compreso, può essere generalmente suddiviso in due 
fasi: la permeabilizzazione della membrana mitocondriale esterna e l'apertura del 
poro di transizione di permeabilità mitocondriale. In base alle condizioni 
sperimentali tali fasi possono essere collegate o indipendenti. Diversi componenti 
che regolano i suddetti processi sono attualmente in fase di studio, poiché si 
sono rivelati bersagli promettenti per il trattamento di numerose malattie, tra le 
quali in particolare il cancro. Infatti, il macchinario apoptotico mitocondriale nelle 
cellule tumorali è strutturalmente e funzionalmente diverso da quello delle cellule 
normali e quindi un gran numero di composti che hanno come target la 
transizione di permeabilità potrebbe per tale motivo esibire una selettività 
tumorale. 
In questo contesto, una famiglia di composti noti come amine biologicamente 
attive acquista un'importanza crescente. Queste amine, tra cui le più note sono 
spermina, spermidina, putrescina e agmatina, sono molecole policationiche a pH 
fisiologico, naturalmente presenti in quasi tutte le specie viventi, in cui esercitano 
un ruolo essenziale per la crescita e la differenziazione cellulare. È da notare che 
la via biosintetica delle poliamine è molto attiva nelle cellule tumorali e che 
concentrazioni elevate di poliamine sono spesso presenti in cellule tumorali in 
divisione ed in tessuti in proliferazione. Inoltre, la de-regolazione del metabolismo 
delle poliamine può indurre l'apoptosi. Per questi motivi, il loro ruolo primario 
nella regolazione della proliferazione e della morte cellulare ha portato gli 
scienziati a studiarne il ruolo a livello mitocondriale. Il target principale delle 
amine biologicamente attive sembra essere la transizione di permeabilità 
mitocondriale: spermina, spermidina e putrescina esibiscono un'azione inibitoria 
mentre l’agmatina (nel fegato) si comporta da induttore o inibitore, a seconda 
delle concentrazioni usate. Inoltre nei mitocondri è stata dimostrata l’esistenza di 
due trasportatori specifici: uno per spermina, spermidina e putrescina ed uno per 
l’agmatina. 
 
Lo scopo di questo lavoro è quello di studiare l'azione delle amine 
biologicamente attive quali regolatrici della permeabilizzazione della membrana 
mitocondriale esterna e del rilascio dei fattori pro-apoptotici in mitocondri isolati 
da fegato di ratto. In particolare viene analizzata la loro interazione specifica con 
le strutture di membrana, allo scopo di chiarire il loro meccanismo di azione. 
La prima parte del lavoro evidenzia il duplice effetto dell’agmatina sul processo di 
transizione di permeabilità. In particolare l'attenzione è focalizzata sull’effetto 
inibitorio dell’amina nei confronti dell’apertura del poro di transizione 
mitocondriale. Infatti, nonostante il suo effetto protettivo sulla transizione di 
permeabilità, l'amina è in grado di indurre il rilascio di alcuni fattori pro-apoptotici. 
Una possibile spiegazione considera l'induzione della permeabilizzazione della 
membrana mitocondriale esterna. 
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Un'ulteriore conferma di questa ipotesi è trattata nella seconda parte della tesi, 
per mezzo del confronto tra gli effetti mostrati dall’agmatina e dal suo analogo 
alfa-metil-agmatina, un più potente inibitore della transizione di permeabilità 
mitocondriale. L’utilizzo di tale analogo permette di escludere che la produzione 
di perossido di idrogeno osservata in presenza di agmatina sia una delle cause 
principali della permeabilizzazione della membrana esterna.  
 
Nella terza parte, è riportato l'effetto delle poliamine (in particolare della spermina 
e della spermidina) sulla permeabilizzazione delle membrane mitocondriali e sul 
rilascio dei fattori pro-apoptotici. Nonostante la ben nota azione protettiva di 
questi composti nei confronti dell'apertura del poro, spermina e spermidina 
condividono con l’agmatina un comportamento simile nell'indurre il rilascio di 
alcuni fattori pro-apoptotici, sebbene attraverso meccanismi diversi. Il loro 
meccanismo d'azione è perciò indagato, cercando di mettere in evidenza le 
specifiche componenti di membrana coinvolte. 
 
Infine, nella quarta parte, viene mostrato uno studio sul meccanismo di efflusso 
della spermina, indagandone il possibile collegamento con l'efflusso di ATP e 
fosfato, molto probabilmente in modo elettricamente neutro. Questa osservazione 
è supportata dall'uso di inibitori specifici della traslocasi degli adenin nucleotidi e 
del fosfato.  
 
In conclusione, i risultati ottenuti in questo studio innanzitutto sostengono l'ipotesi 
che la permeabilizzazione delle membrane interna ed esterna possa essere vista 
come due distinti processi, anche se spesso legati tra loro. Inoltre è possibile 
affermare che la permeabilizzazione della membrana mitocondriale esterna 
potrebbe essere un punto di contatto tra apoptosi intrinseca ed estrinseca, 
essendo indotta sia da segnali intra- che extra-mitocondriali. E’ da considerare 
che il rilascio di citocromo c dai mitocondri non porta in ogni caso all'induzione 
dell'apoptosi. In particolare lo stato redox della proteina è cruciale per la 
successiva cascata di eventi: solo il citocromo c ossidato, infatti, è in grado di 
innescare l'apoptosi. Per questo motivo, è ragionevole pensare che il rilascio di 
citocromo c indotto dalle amine biologicamente attive possa rappresentare un 
punto di partenza, ma non un punto di non ritorno. In questo contesto, le 
poliamine rappresentano uno strumento utile per studiare sia la 
permeabilizzazione della membrana esterna mitocondriale che la transizione di 
permeabilità mitocondriale, cercando di delinearne le caratteristiche strutturali e 
funzionali. Inoltre, a livello cellulare, le poliamine sono in grado di prevenire o 
indurre l’apoptosi e quest'ultimo effetto è causato dal loro metabolizzazione da 
parte delle amine ossidasi, con la produzione di composti citotossici. Questa 
azione dicotomica dipende dalla concentrazione delle poliamine, che è modulata, 
come dimostrato dai nostri dati, anche attraverso il loro ciclaggio all’interno dei 
mitocondri. Nonostante siano chiaramente necessari ulteriori studi per individuare 
tutti i meccanismi strutturali coinvolti nel loro ciclaggio, almeno per la spermina, 
viene individuata una possibile via di efflusso. 
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Abbreviations 
MeAGM   alpha-methyl-agmatine 
ADC    arginine decarboxylase 
AdNT    adenine nucleotide translocase 
AGM    agmatine 
AIF    apoptosis inducing factors 
Bak    Bcl-2 agonist or killer 
Bax    Bcl-2 associated X protein 
Bcl-2    B cell lymphoma 2 
BKA    bongkrekic acid 
CsA    cyclosporin A 
CypD    cyclophylin D 
Cyt. c    cytochrome c 
HRP horseradish peroxidase 
I2 imidazoline receptor type 2 
IAPs    inhibitor of apoptosis proteins 
IM    inner membrane 
MAO     monoamine oxidase 
MOMP    mitochondrial outer membrane permeabilization 
MPT mitochondrial permeability transition 
MPTP mitochondrial permeability transition pore 
OM    outer membrane 
PUT    putrescine 
RLM    rat liver mitochondria 
ROS    reactive oxygen species 
RR    ruthenium red 
SDS    sodium dodecyl sulfate 
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Smac/DIABLO Second mitochondria-derived activator of caspase/ 
Direct IAP binding protein with low pI 
SPD    spermidine 
SPM    spermine 
TPP+    tetraphenylphosphonium 
VDAC    voltage-dependent anion channel 
E    electrode potential variation 
pH    chemical gradient 
 mitochondrial electric membrane potential 
H
+    electrochemical gradient 
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Introduction 
Mitochondria 
Mitochondria, also termed as the cell “powerhouses” for their ability to convert 
redox energy in ATP, are small double-membrane organelles implicated in the 
regulation of the life and death of eukaryotic cells. Indeed, they are implicated in 
the modulation of several metabolic processes culminating in the synthesis of 
ATP, but also in phospholipids and heme synthesis. Moreover, besides regulating 
the levels of intracellular signaling molecules (e.g., Ca2+ and reactive oxygen 
species (ROS)), they are also activators of the “intrinsic” apoptotic pathway 
[Osellame et al., 2012; Tait and Green, 2012].  
Mitochondrial bioenergetic activity is strongly dependent on the integrity of 
mitochondrial membranes (particularly the inner one), given that its insulating 
properties are fundamental for the correct electron flux along the respiratory 
complexes and consequently for the establishment of the electrochemical 
gradient (µH+), characteristic of these energy transducing membranes. As it is 
well-known, µH+ is given by the sum of the electrical transmembrane potential 
() and the chemical gradient (pH), expressed in mV.  
The organelle morphology differs among cell types: from solitary organelles in 
hepatocytes to an intricate network in many epithelial cells [Scorrano, 2013]. In 
hepatocytes and fibroblasts they are typically characterized by a length of 3-4 µm 
and a diameter of 1 µm, resembling approximately small bacteria in size and 
shape. The number of mitochondria per cell is also variable from cell type to cell 
type. According to the classic model of Palade [Palade, 1952], mitochondria have 
an outer membrane (OM) and an inner membrane (IM), the latter being 
characteristically invaginated and forming sheet-like structures called cristae. As 
showed in Fig. 1, this organization was hypothesized to generate an 
intermembrane space (enclosed by the OM and the IM) and a matrix (enclosed 
by the IM) [Scheffler, 2001]. 
 
Fig. 1 The classical morphological model of mitochondria. 
 8 
 
However more recent studies exploiting the technique of electron tomography, 
have modified this view, whereby additional subdivision of the IM lead to the 
formation of the inner boundary membrane and the cristae, which are identified 
as separated compartments. Their continuity with the inner boundary membrane 
is achieved by narrow tube-like structures called cristae junctions (Fig. 2) 
[Scheffler, 2001; Scorrano, 2013]. 
 
Fig. 2 The new morphological model of mitochondria. 
Mitochondria and Ca2+ 
Ca2+ is an important signaling molecule not only in cells, but also in mitochondria 
that maintain a large Ca2+ gradient across their IM, achieved through an 
extensively studied mechanism of accumulation. The direct demonstration of this 
process in isolated mitochondria was published in 1961, when the work of 
DeLuca and Engstrom demonstrated the ability of kidney mitochondria to 
accumulate large quantities of Ca2+ with a mechanism requiring ATP, Mg2+ and 
inorganic phosphate. Only recently the electrophoretic uniporter responsible for 
Ca2+ uptake has been identified as a 40 kDa protein of the IM [De Stefani et al., 
2011]. On the other hand, the efflux mechanism is regulated through a Na+/Ca2+ 
exchanger, whose activity was identified by Carafoli and collaborators [1974], and 
an H+/Ca2+ antiporter described in some mitochondrial types [Fiskum et al., 
1979]. Several mitochondrial enzymes are regulated by Ca2+, thus justifying the 
necessity of a bidirectional flux or, as proposed by several authors, a Ca2+ cycling 
mechanism. Moreover, the accumulation of high Ca2+ concentrations in the 
presence of phosphate, as demonstrated by Lötscher and collaborators [1980], 
may lead to complete and irreversible depolarization of the organelle. These 
conditions cause an alteration of the IM permeability termed mitochondrial 
permeability transition (MPT), (see pag. 10). As Grijalba and collaborators [1999] 
demonstrated, Ca2+ alters the lipid organization of the IM, by its interaction with 
the anionic head of the phospholipid cardiolipin (IM). These alterations in 
membrane organization may compromise the conformation and subsequently the 
functionality of membrane components (including coenzyme Q), thus affecting 
respiratory chain function. As a result, the generation of cytotoxic ROS is favored. 
[Vercesi et al., 1997] 
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Mitochondrial ROS production 
Mitochondrial clearly play a crucial role in regulating the redox state of the cell. 
Indeed, the respiratory chain is the primary putative source of ROS, mainly 
produced during the flow of electrons through complexes I, II and III [Murphy, 
2009; Moreno-Sánchez et al., 2013]. Normally, the generated ROS are in a 
sufficient small amount to be removed by the scavenging systems of the 
organelle, which include superoxide dismutase, catalase, glutathione and 
thioredoxin reductase. However, when ROS production overcomes the ROS 
scavenging capacity (e.g., in the presence of exceeding amounts of Ca2+ and 
phosphate, as described in the precedent section, and/or when scavenging 
pathways are inactivated), accumulated high ROS can cause several damages in 
both mitochondria and the rest of the cell [Kowaltowski et al., 2001; Murphy, 
2009].  
In mitochondria, the above mentioned oxidative damage can cause alterations of 
the redox state of both membrane and matrix components (glutathione, thiols, 
electron transport chain complexes) and DNA, all of which clearly hamper 
mitochondrial functions. In these conditions, mitochondria are clearly not able to 
perform their metabolic functions. Indeed, mitochondrial oxidative stress have 
been demonstrated to be a fundamental step in the induction of apoptosis in RLM 
[Halestrap et al., 1993], (but not in brain mitochondria [Grancara et al., 2011]).  
 
Mitochondria and apoptosis 
Cell death can be classified as apoptotic (programmed) or necrotic (accidental), 
even if the boundaries between these two forms are not always clearly defined 
[Osellame et al., 2012].  
Apoptosis is an active and coordinated process that requires energy to occur and 
is fundamental for the development of the organisms, removing exceeding, 
damaged or aged cells. It can occur through two signaling pathways: the extrinsic 
pathway, which involves cell surface receptors and culminates with the activation 
of caspase 8, and the intrinsic pathway, which requires mitochondrial 
permeabilization.  
Conversely, necrosis is the result of a metabolic failure that leads to the cell 
“energy collapse”, leading to the breakdown of ion gradients, cell swelling, and 
structural disorganization.  
According to Osellame and collaborators [2012], the rupture of mitochondrial 
membranes is crucial for both apoptotic and necrotic processes, although they 
claim that, while the activation of the MPT is one of the major mechanism driving 
necrosis, the mitochondrial outer membrane permeabilization (MOMP) is 
characteristic of the intrinsic apoptotic process. Halestrap [2005], instead, 
distinguishes between the induction of transient MPT (in which ATP production is 
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maintained) leading to apoptotic cell death, and permanent MPT induction, (in 
which ATP content is depleted) leading to necrotic cell death. Clearly, in both 
hypotheses the permeabilization of mitochondrial membranes appears crucial to 
the cell death machinery. 
Mitochondrial permeability transition and controversies 
Under normal physiological conditions, the mitochondrial IM is permeable only to 
a few, selected metabolites and ions. However, in response to noxious stimuli 
(e.g., Ca2+ overloading, oxidative stress, cytotoxic agents), a non-specific pore, 
the so-called mitochondrial permeability transition pore (MPTP), opens in the 
contact sites between the IM and OM, allowing the passage of molecules with 
molecular masses up to 1.5 kDa. It is to underline that, even though both 
membranes seem to be eventually involved, the MPT is essentially a process of 
the IM, given that experiments using mitoplasts (i.e., mitochondria deprived of the 
OM) showed all the same a typical MPT [Dalla Via et al., 2014; Siemen and 
Ziemer, 2013], with disrupted permeability of the IM and passage of solutes 
across it. The free passage of protons then causes the uncoupling of oxidative 
phosphorylation and hydrolysis of ATP. As a consequence, retention of proteins 
in the matrix (due to the pore dimensions) ensues a colloid-osmotic pressure 
allowing the entry of water into the matrix, mitochondrial swelling, cristae 
unfolding, matrix expansion, all of which finally disrupt the OM with the release of 
mitochondrial proteins including cytochrome c (cyt. c), Second mitochondria-
derived activator of caspase/Direct IAP binding protein with low pI 
(Smac/DIABLO), Apoptosis Inducing Factor (AIF) [Halestrap, 2005; Brenner and 
Moulin, 2012].  
Several studies have addressed the issue of MPTP as a dynamic multiprotein 
complex and the proposed composition involved different interacting proteins: the 
adenine nucleotide translocator (AdNT), the matrix peptidyl-prolyl isomerase 
cyclophillin D (CypD), the phosphate carrier, but also the OM protein voltage-
dependent anion channel (VDAC), and the cytosolic and intermembrane space 
hexokinase and creatine kinase, respectively. Since the mid-1990s, several 
MPTP candidates have been knocked out in mice, but these genetic studies have 
failed to support their implication in the pore. In particular, they suggest a 
regulatory function for AdNT and CypD and exclude an essential role for VDAC 
[Brenner and Moulin, 2012]. Conversely, a recently proposed hypothesis 
suggests that MPTP is composed by dimers of F0F1-ATP synthase that, when 
incorporated into lipid bilayers, are able to form Ca2+-activated channels, with 
features in common to the MPTP studied in situ [Giorgio et al., 2013]. 
Further studies are clearly required to clarify the MPTP composition, which 
remains an extremely important scientific issue, in view of the possible 
involvement of the MPTP in mitochondria-associated dysfunctions that warrants 
development of mitochondria-targeting drugs. 
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Pro-apoptotic factors 
The release of pro-apoptotic proteins from mitochondria is a well-known crucial 
process to activate the cell death machinery. Among them, this work has focused 
primarily on cyt. c, Smac/DIABLO and AIF.  
Cyt. c is a 12.5 kDa soluble metalloprotein located to the side of the IM facing the 
intermembrane space; which shuttles electrons from Complex III (cytochrome c 
reductase) to Complex IV (cytochrome c oxidase) of the respiratory chain [van 
Gurp et al., 2003]. The presence of different pools of cyt. c has been proved: 
loosely bound pools are mainly bound to membrane phospholipids (especially 
cardiolipin) by electrostatic interactions whereas tightly bound pools are partially 
embedded into the IM due to hydrophobic interactions [Ott et al., 2001]. In 
response to several pro-apoptotic stimuli, leading to the OM permeabilization, cyt. 
c is released into the cytosol where it binds dATP and Adaptor molecule 
apoptosis-Protease Activating Factor I, initiating the formation of the apoptosome. 
This complex, in turn, starts the activation of the caspase cascade, leading to 
chromatin condensation, DNA fragmentation and cell death [Dalla Via et al., 
2014].  
Smac/DIABLO is a 23 kDa protein present in the intermembrane space that, 
upon the OM permeabilization, is released into the cytosol [Maly, 2007]. The 
physiologic function of Smac/DIABLO is still unknown, although it has been 
reported that it enhances apoptosis by binding to members of the inhibitor of 
apoptosis proteins (IAPs) family. Smac/DIABLO competes with the caspases for 
the (inhibitory) binding to IAPs, because this factor has regions structurally similar 
to those that in caspases bind IAPs. Thus, IAPs inhibitory effect is removed by 
Smac/DIABLO and caspases are able to act in apoptosis [van Gurp et al., 2003; 
Dalla Via et al., 2014].  
AIF is a type-I IM protein (62 kDa), whose N-terminal portion is exposed to the 
matrix and the C-terminus protrudes into the intermembrane space [Otera et al., 
2005]. In physiological conditions AIF exhibits antioxidant activity and is required 
for the correct assembly and maintenance of Complex I of the respiratory chain 
[Vahsen et al., 2004]. The release of AIF into the cytoplasm is caused by its 
cleavage to a 57 kDa protein in response to apoptotic signals. The released AIF 
induces nuclear apoptosis in a caspase-independent manner by translocating to 
the nucleus and inducing DNA fragmentation and chromatin condensation [Dalla 
Via et al., 2014].  
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Mitochondrial outer membrane permeabilization 
As emphasized, there are two main models that account for the release of pro-
apoptotic factors during mitochondria-mediated apoptosis [Green and Reed, 
1998]. In one model, the permeabilization of mitochondrial membranes occurs 
through MPTP formation, involving both the mitochondrial membranes, whereas 
the other one conceives the main involvement of MOMP. The latter process is 
characterized by the formation of channels in the OM (taking place independently 
of mitochondrial swelling), and can be induced by stimuli such as hypotonicity, 
hydrogen peroxide, and pro-apoptotic B cell lymphoma 2 (Bcl-2) family proteins 
[Arnoult et al., 2002; Gogvadze et al., 2006].  
According to the function, Bcl-2 proteins can be divided into anti-apoptotic and 
pro-apoptotic members. This latter group is further divided into two subfamilies 
based on the presence of specific Bcl-2 homology domains (BH1, BH2 and BH3): 
Bcl-2 associated X protein (Bax) and Bcl-2 agonist or killer (Bak), sharing BH1-
BH3 domains, are the effectors of MOMP; while BH3-only proteins can interact 
with Bax and Bak, or with the other anti-apoptotic members [Green and Kroemer, 
2004]. These proteins share structural similarity with bacterial pore forming 
toxins, suggesting that they can act similarly in the OM [Tait and Green, 2010]. 
According to Bleicken and collaborators [2013], after the translocation of Bax to 
the OM, Bax and Bak changes of conformation occur, leading to their 
oligomerization and to the formation of pores. However, the exact mechanism by 
which Bcl-2 proteins regulate this process is still a matter of debate. 
 
Fig. 3 Intrinsic and extrinsic pathways of apoptosis. 
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Biologically active amines  
Biologically active amines represent a class of compounds physiologically 
synthesized in living organisms. According to a classification proposed by COST 
actions 917 and 922 (research programs financed by the Commission of the 
European Communities DG/XIIB), active amines are distinguished in polyamines 
(putrescine, spermidine and spermine) and biogenic amines (agmatine, 
serotonin, tyramine, histamine, phenylethylamine, tryptamine and 
cathecolamines) [Toninello et al., 2004]. 
 
Polyamines 
 
Fig. 4 Polyamines. 
Putrescine (PUT), spermidine (SPD) and spermine (SPM) are decarboxylation 
products of ornithine and S-adenosyl-methionine metabolism in nearly all 
eukaryotic cells. Under physiological conditions, these molecules are fully 
protonated (poly)cations [Agostinelli et al., 2010]. Polyamines total intracellular 
concentration is in the mM range, although the majority is bound to various 
anions in the cell, such as DNA, RNA, proteins, and phospholipids [Casero and 
Marton, 2007]. These amines share a multitude of functions affecting cell growth 
and proliferation, e.g., regulation of gene transcription, posttranscriptional 
processes, ion channels, and protein kinases activity; modulation of membrane 
structures/functions, structure and stability of nucleic acids; and progress of the 
cell cycle [Pegg and Casero, 2011].  
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Polyamines and diseases 
The interest in polyamine research has increased since the realization that 
polyamines and their metabolites may play critical roles in human diseases. 
Indeed, alterations of polyamine levels and metabolism have been detected in 
many diseases (e.g., chronic renal failure, liver cirrhosis, cystic fibrosis, 
Alzheimer’s and Parkinson’s Diseases, Duchenne muscular dystrophy and 
cancer). With regard to cancer, increased polyamines concentrations have been 
found in many solid tumors, and similar increases in urinary and serum 
polyamine content are common features of malignancy. Moreover, the polyamine 
biosynthetic pathway is more active in tumor tissues, making it an attractive 
target for the design of chemotherapeutic drugs [Wallace and Fraser, 2004]. 
 
Cellular transport of polyamines  
The cellular content of polyamines, which plays, as above mentioned, important 
roles in cell proliferation and differentiation, is highly regulated by their 
biosynthesis, degradation, and transport processes. With regard to their transport 
in mammalian cells, a specific transporter has not been yet identified, although it 
was found that polyamine accumulation is energy-dependent and selective. It has 
been proposed that polyamines are imported first by a plasma membrane carrier 
and then sequestered into preexisting vesicles [Hoshino et al., 2005]. Very recent 
advances in the field described by Nowotarski and collaborators [2013] suggest 
two other mechanisms for polyamines import: the first supports the binding of 
SPM on heparan sulfate groups of glypican 1 on the cell surface, with the 
subsequent internalization of the amine. SPM is then freed by a nitric oxide-
oxidation-mediated process. The other proposition suggests a caveolin-1-
dependent internalization. The subsequent release of the internalized 
compounds has been described only for PUT through the solute carrier family 3 
member 2 exporter, while a nitric oxide synthase 2-dependent reaction is thought 
to destabilize the SPM-receptor complexes. 
 
Polyamines and mitochondria 
Mitochondria apparently lack a polyamine biosynthetic pathway, although 
substantial quantities of SPM and SPD have been detected in heart, liver and 
brain mitochondria, as a consequence of a transport system present in the 
membranes of these organelles [Toninello, 2001]. The first demonstration of a 
polyamine transport system in the mitochondrial membranes was published by 
Toninello and collaborators in 1985, by evidencing that SPM internalization in 
mitochondria occurs through an energy-dependent mechanism. Further 
investigations [Dalla Via et al., 1996; 1999; Toninello et al., 1992a; 1992b] 
identified two binding sites for SPM and SPD, both with mono-coordination, low 
affinity and high binding capacity, whereas only one binding site was evidenced 
for PUT. This site was correspondent to one of the binding sites for SPM and 
SPD. The polyamines were demonstrated to be mutually competitive inhibitors, 
indicating a common transport system.  
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The structure of these amines allows their specific interaction with mitochondrial 
membranes and it is probably responsible for the variety of effects ascribable to 
these molecules (e.g., activation of the mitochondrial uptake of hexokinase and 
protein kinases CKI and II, stimulation of the activity of pyruvate dehydrogenase, 
and inhibition of ATP hydrolysis, by the F1-ATPase [for a review see Toninello et 
al., 2004]). The main target of polyamines seems to be the MPT and Toninello 
and collaborators reported for the first time in 1984 the ability of SPM to prevent 
Ca2+-induced MPT in RLM. Several subsequent studies confirmed its inhibitory 
effect not only in liver [Tassani et al., 1995], but also in other organs (e.g., heart 
[Toninello et al., 1990], intestine [Anup et al., 1999]). The protective effect of 
polyamines on MPT induction is not completely understood and several 
mechanism have been investigated in order to elucidate their activity [Toninello et 
al., 2004]. Besides the stabilization of mitochondrial membranes due to their 
charged molecule [Lapidus and Sokolove, 1993], one of the main actions of 
polyamines, in particular of SPM, resides in their antioxidant properties [Sava et 
al., 2006]. SPM is able to exhibit a scavenging action by reacting with the 
hydroxyl radical (OH·-) and resulting in the production of SPM dialdehyde (1,12-
bis-1,12-dioxo-4,9-diazododecane). Taking into account that MPT opening is 
linked with the so-called redox catastrophe [Susin et al., 1998], the above 
described effect is undoubtedly fundamental in explaining SPM inhibition of MPT.  
Despite this effect, and thus the anti-apoptotic potential of polyamines, Stefanelli 
and collaborators [2000] reported also a CsA-insensitive release of cyt. c induced 
by these molecules in rat heart mitochondria. This effect was demonstrated to be 
independent from mitochondrial damage and probably the pool of cyt. c released 
was not part of the electron transport chain, a possibility supported by the 
evidence of the presence of different cyt. c pools in mitochondria [Ott et al., 
2001].  
 
Agmatine 
 
Fig. 5 Agmatine. 
Discovered in 1910 by the Nobel Laureate Albrecht Kossel [Kossel, 1910], 
agmatine (AGM) [1-(4-Aminobutyl)guanidine] is an ubiquitous biogenic amine 
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with two positive charges at physiologic pH. In mammals, it is synthesized from 
arginine by the enzyme arginine decarboxylase (ADC) (mainly in brain), although 
a great deal of AGM may be absorbed from the diet [Salvi et al., 2006]. 
Burgeoning research shows that AGM is implicated in multiple biological 
functions as: ligand of -adrenergic and imidazoline receptors type 2 (I2); 
neuromodulator and co-transmitter; modulator of some arginine metabolic 
pathways; inductor of nitric oxide synthesis, and modulator of polyamine 
metabolism [for a review on AGM see Piletz et al., 2013].  
Agmatine and diseases 
After the discovery of the first neuroprotective effects of AGM in 1995, the 
research involving this amine increased rapidly on several areas such as neuro-, 
nephron- and cardioprotection [Piletz et al., 2013]. This resulted in reports 
showing that, from the first human clinical trials, oral AGM is safe and effective in 
alleviating neuropathic pain [Keynan et al., 2010]. Intriguingly, depending on the 
cell type and its stage of proliferation, it has also been shown that AGM exhibits 
antiproliferative effects in rat hepatoma cells [Gardini et al., 2003] and in leukemia 
cells [Haenisch et al., 2011], but it can also induce intrinsic apoptosis in non-
proliferative hepatic cells [Gardini et al., 2001] and counteracts tumor necrosis 
factor- in retinal ganglion cells [Hong et al., 2009]. In conclusion, the complexity 
of AGM actions is summarized by the following statement by Piletz and 
collaborators [2013]: “AGM is now considered to be capable of exerting 
modulatory actions simultaneously at multiple target sites, thus fitting the 
therapeutic profile of a ‘magic shotgun’ for complex disorders”.  
Cellular transport of agmatine  
As previously mentioned, AGM may also come from the diet. After being 
absorbed by the stomach, AGM is taken up by several organs, in particular by the 
liver. Being (di-)protonated, to pass across the membranes, AGM needs a 
transport that, in hepatocytes [Cabella et al. 2001], endothelial [Babál et al., 
2000], and kidney cells [Del Valle et al., 2001] is likely the same mechanism 
exploited by polyamines (see above). However in glyomal cells [Molderings et al., 
2001] and in a cell line derived from human embryonic kidney, AGM may use a 
different means. In particular, in the latter case, the involvement of the 
extraneuronal monoamine transporter and the organic cation transporter 2 may 
be also suggested [Gründemann et al., 2003]. 
Agmatine and mitochondria 
AGM is transported in mitochondria, where also its metabolic enzymes ADC and 
agmatinase are present, as well as the I2, a 60 kDa protein that localizes to the 
OM and constitutes a monoamine oxidase (MAO) domain [Raddatz et al., 2000].  
Previous data, on AGM activity in isolated RLM, have demonstrated that AGM 
may have different effects on mitochondrial bioenergetics that depend on the 
concentrations used: at low concentrations (10-100 μM) it may act as a typical 
amplifier of the Ca2+ (plus phosphate) induction of MPT, while at high 
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concentrations (1 mM) it inhibits this phenomenon [Battaglia et al., 2007]. It is 
necessary to point out that the discrimination between low and high 
concentrations is not arbitrary, but it is based on previous published data 
demonstrating that AGM concentration in hepatocyte cytosol is about 0.5 mM 
[Gardini et al., 2001]. In this respect, it is necessary to remind that AGM 
permeates both the mitochondrial membranes (presumably at OM/IM contact 
sites) using a specific electrophoretic transporter, a channel or a single-binding 
centre-gated pore, which was identified in RLM [Salvi et al., 2006]. Analyses, 
applying a thermodynamic approach developed by Di Noto and collaborators 
[1996, 2002], have demonstrated the presence of two binding sites (S1 and S2) 
for AGM on mitochondrial membranes, both with mono-coordination [Martinis et 
al., 2012]. S1 is probably localized on the I2 that, as previously mentioned, is itself 
a MAO domain. Because AGM can inhibit MAO activity, its binding to S2 further 
underlines the importance of the molecule. Finally, the work proposes a 
hypothesis concerning AGM binding sites: S1 sensing AGM concentration 
(outside mitochondria) eventually modifies the properties of S2, the transport site. 
AGM induction of the MPT, at low concentrations, is triggered by the oxidation of 
AGM, probably catalyzed by a copper-dependent amine oxidase present in RLM 
[Cardillo et al., 2009]. This enzyme can be responsible for the large amount of 
H2O2 detected in presence of AGM (both in the presence or the absence of Ca
2+). 
The ROS produced results in the bioenergetics collapse of the organelle and in 
the activation of the intrinsic pro-apoptotic pathway. On the contrary, a completely 
different scenario is observable at higher concentrations: AGM is able to inhibit 
the MPT induced by Ca2+ (plus phosphate), probably due to its antioxidant 
properties. In fact, in these conditions, the amine is able to generate an oxidative 
stress, but the amount of still unreacted molecules may act as a scavenger, thus 
exhibiting self-protection. This scavenger mechanism exhibited by AGM is 
applicable when the targeted ROS is the OH·-: unprotonated AGM reacts with 
OH·- to form dihydroxyaminobutyl-guanidine and, subsequently, guanidobutyric 
aldehyde by the spontaneous dehydration and hydrolysis, with a reaction already 
proposed for SPM [Sava et al., 2006].  
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Materials and methods 
Mitochondria isolation 
Mitochondrial preparation from rat liver was performed by using the modified 
method of Schneider and Hogeboom [1950] by conventional differential 
centrifugation. All operations were carried out at a temperature of 4°C, 
maintaining the equipment in melting ice. 
The liver was taken from Wistar rats of (200-300 g), after 16 hours fasting, 
minced and washed in an isolation medium with 250 mM sucrose, 5 mM 
Hepes and 2 mM EGTA (pH 7.4). After washing out the blood, the minced 
organ was homogenized using a Potter homogenizer with a Teflon pestle. 
The homogenate was centrifuged in a Beckman J2-21 centrifuge, with Ja-17 
rotor, cooled at 0-5°C. The first low-speed centrifugation, at 2300 rpm (755 g) 
for 10 min, is used to remove nuclei and intact cells. The supernatant, 
containing mitochondria, microsomes, and cytosol, was subjected to a 
second centrifuge at 9000 rpm (10800 g) for 10 min. This centrifugation 
allows the separation of mitochondria (pellet fraction) from microsomes and 
cytosol (supernatant). From the walls of the test tubes deposited fat was 
removed with tissue paper and then the pallet was washed with a medium 
without EGTA to remove additional fat residues. The pellet was resuspended 
in 20-30 ml of medium and homogenized by hand in a test tube Potter. The 
obtained suspension was washed in a final centrifuge at 11000 rpm (15900 g) 
for 5 minutes. The supernatant was removed and the pellet was washed 
gently to remove the surface film, consisting of broken or damaged 
mitochondria. The pellet was then resuspended in 2 ml of medium and it was 
homogenized by hand in a small test tube Potter. The content was then 
stored in a test tube immersed in melting ice. 
 
 
Fig. 6 Schematic summary of the preparation of rat liver mitochondria. 
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Protein content determination 
The protein content of the mitochondrial suspension, was measured by the 
biuret method with bovine serum albumin as standard [Gornall et al., 1949]. 
The method uses the formation of a violet complex between rameic ion and 
amidic nitrogen of proteins (biuret reaction). 
The Gornall solution contains: 
• Rameic sulphate (CuSO4 • 5 H2O) 1.5 g/l 
• Sodium and potassium tartrate (NaKC4H4O6 • 4 H2O) 6 g/l 
• Sodium hydroxide (NaOH) 30 g/l 
Preparation of Gornall reagent: 
1.5 g of rameic sulfate and 6 g of sodium and potassium tartrate are placed in 
500 ml of bidistilled water. Under constant stirring 300 ml of NaOH 10% (w/v) 
are added and made up to volume with bidistilled water up to reach a final 
liter. 
The reagent thus prepared should be stored in the dark, due to its sensitivity 
to light. 
Procedure 
Five test tubes are prepared (one blank, two samples, two serum albumin 
standards) according to the scheme reported in Table 1. 
 Blank Sample1 Sample2 
Standard 1 
1 mg/3 mL 
Standard 2 
2 mg/3 mL 
H2O 
 
Deoxycholate 3% 
 
Isolated mitochondria 
 
Albumin (4 mg/mL) 
 
Gornall Reagent 
0.500 
 
1.000 
 
- 
 
- 
 
1.500 
0.475 
 
1.000 
 
0.025 
 
- 
 
1.500 
0.475 
 
1.000 
 
0.025 
 
- 
 
1.500 
0.250 
 
1.000 
 
- 
 
0.250 
 
1.500 
- 
 
1.000 
 
- 
 
0.500 
 
1.500 
 
Table 1. Outline of the protein assay according to the method of Gornall. 
All amounts are expressed in ml. 
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The standard is used for the construction of the calibration line. To verify the 
correct preparation of the reagent of Gornall is considered that 1 mg of 
albumin with reagent gives an absorbance of 0.090 in a spectrophotometer at 
a wavelength of 540 nm. 
The reagent of Gornall acts by complexing the proteins according to the 
reaction of biuret, and produces a violet color whose absorbance maximum is 
at 540 nm. The reaction takes place at 30°C for 10 minutes. 
The blank is used to calibrate the spectrophotometer and to make sure that 
the absorbance of the samples are due only to the mitochondrial proteins 
present. 
The absorbance of the two samples are measured at 540 nm in an UV/VIS 
KONTRON UVIKON 922 spectrophotometer. 
The formula, derived from the calibration line, by which we are able to 
calculate the volume in which is present a milligram of mitochondrial proteins 
is : 
 
and it is derived from the composition of two proportions:  
 
x:25µl=1mg:V(µl→?) 
 
1 mg prot : 0.090 = x : Amedia 
 
Standard medium for mitochondrial incubation 
Mitochondria (1 mg/ml) were incubated in the following medium: 
component concentration 
Sucrose 200 mM 
Hepes 10 mM 
Succinate 5 mM 
Rotenon 1.25 M 
Phosphate 1 mM 
 
Table 2. Composition of the standard medium of incubation. 
The medium was at pH 7.4 and 20°C. All variations or additions at this 
medium will be reported in the appropriate captions in the result section. 
100
44.44
1
max



A
V
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Transmembrane potential measurement with 
ionoselective electrode 
The transmembrane electric potential () was measured using a specific 
electrode on the basis of distribution of the lipid-soluble cation 
tetraphenylphosphonium (TPP+) [Affolter and Sigel, 1979; Kamo et al., 1979]. 
The electrode is a complex semipile formed by an anion reversible electrode, 
at Cl- (inner reference electrode), inserted in a case containing a TPP+Cl- 
solution at known concentration, at contact with a TPP+ permeoselective 
membrane. This semipile exhibits an electric potential that changes with 
logarithm of TPP+ activity in the sample. It is coupled with an electrode at 
constant potential (outer reference electrode) and formed a pile, with an 
electroengine force/power that results linear function of activity logarithm of 
the ion to measure. 
The membrane separates two solution at different concentration of the same 
electrolyte (TPP+Cl-): TPP+ is the counterion and Cl- is the coordinate ion of 
the membrane, because their charges are respectively opposite and equal to 
the charge in the membrane structure, given by tetraphenylborate (TPB-). The 
membrane is a cationic membrane, because is permeable to TPP+. 
The pile exhibits a potential variation (E), that is measure of the proceed of 
the process of counterions transfer from high concentration solution c’’ (fixed) 
to lower concentration solution c’ (unknown), with c’’>c’. 
 
 
Fig. 7. TPP
+
 selective electrode. 
 
The inner and outer electrode potentials are constant, and the potential 
difference of the pile is determined only by membrane potential (function of the 
ratio between unknown and known concentration of the counterion TPP+) and 
interliquide potential (EL), minimized by KCl saturated saline bridge. 
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The E results: 
21 EEE     
Xk EEE  '1  
Lk EEE  ''2    
Where: 
 E1 = ionoselective electrode potential 
 E2 = outer reference electrode potential + interliquide junction potential 
 Ek’ = inner reference electrode potential 
 Ex = ionoselective membrane potential difference 
 Ek’’ = outer reference electrode potential 
 EL = interliquide junction potential ≈0 
LkXk EEEEE  '''  
Xkk EEEE  '''  
Setting: Ek’ – Ek’’ = z (constant) 
Then: 
'log
3.2
''log
3.2
00 c
nF
RT
Ec
nF
RT
EEX   
Setting: Uc
nF
RT
E  ''log
3.2
0   (constant) 
The ionoselective membrane potential difference (Ex) becomes: 
'log
3.2
c
nF
RT
UEX   
And pile E results: 
'log
3.2
0 c
nF
RT
EUzE   
 
Finally, setting: KEUz  0 , it is obtained: 
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'log
3.2
c
nF
RT
KE       [1] 
Where: 
 K = constant resulting from the algebraic sum of all the constant potentials 
in the electrode 
 F = 96485 coulombs mol-1 = 23.06 Kcal volt-1 mol-1 
 R = 8.341 Joule mol-1 K-1 
 T = 20°C 
The electrode response is linear with the logarithm of TPP+ concentration, with 
an increase of about 58 mV every ten unit of variation in the TPP+ 
concentration, until the concentration decreases to 10-7 M, according to 
Nernst’s equation. 
The  is determined measuring the TPP+ distribution across the 
mitochondrial membrane with the electrode. The mitochondrial membrane is 
permeable to TPP+, that distributes according to Nernst’s equation: 
in
out
in
out
TPP
TPP
TPP
TPP
nF
RT
][
][
log58
][
][
log
3.2




   [2] 
Where: 
 [TPP+]out = outer TPP
+ concentration 
 [TPP+]in = inner TPP
+ concentration 
determining the variation of electrode E. 
Considering the law of mass conservation: 
0][][][
  TPPVTPPvTPPV inout     [3] 
Where: 
 V = medium volume containing 1 mg of mitochondrial proteins (1 ml in our 
system) 
 v = volume of inner mitochondrial space corresponding to 1 mg of 
mitochondrial proteins (≈ 1 l) 
 [TPP+]0 = TPP
+ concentration before mitochondrial addition 
Equation [3] is inserted in [2] and E is correlated to [TPP+]out, with some 
mathematic passages, it is obtained: 
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













 
110log58log58 58
0EE
V
v
    [4] 
Where: 
 E0 = electrode potential difference before mitochondrial addition 
In order to calculate correctly the  it is necessary to know the v/V ratio, that 
is the v value. If mitochondrial volume does not vary during experiment, the 
58 log v/V remains constant. 
The v value was calculated using the [14C]sucrose distribution [Palmieri and 
Klingenberg, 1979], and it corresponds to 1 l/mg of mitochondrial proteins. 
Jensen et al. [1986], comparing the  value obtained measuring the 86Rb 
and that measuring with electrode, propose to correct with the subsequent 
equation: 
92.0
)16.66( mVel
Rb



      [5] 
In which el is the value obtained in [4]. 
Before to proceed in  measure, it is performed the electrode calibration, to 
determine experimentally the ratio 
nF
RT3.2
 
The ratio corresponds to the slope of the line: 
'log
3.2
c
nF
RT
KE   
The calibration was performed in the incubation condition, without 
mitochondria, adding TPP+ and measuring the electrode variation. The final 
concentration of TPP+ should not exceed 1-2 M, because an excessive 
amount of TPP+ can later depolarize the mitochondrial membrane. 
The slope calculation was derived graphically: the measured E values are 
carried in function of log[TPP+]. The E corresponding to an increase in TPP+ 
concentration of ten times is extrapolate. The theoretical value, according to 
Nernst, corresponds to 58 mV. 
After calibration, mitochondria were added to incubation medium, TPP+ enters 
across mitochondrial membrane and distributes between medium and matrix, 
according to Nernst’s equation. A potential difference at the electrode was 
originated respect to the value reached after calibration, named E-E0, and 
registered by the recorder as a deflection (decrease of TPP+) concentration in 
the medium. The fitting of this potential difference variation in the [4] allow to 
obtain the  value. 
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Mitochondrial swelling determination 
Mitochondrial swelling occurs when solute enters in high quantity in mitochondrial 
matrix, e.g., when mitochondrial permeability transition happens, causing an 
increase in the osmotic pressure. Mitochondria, in fact, have the ability to behave 
like osmometers and, therefore, can swell or contract through accumulation or 
expulsion of water, according to the tonicity of the medium in which they are 
suspended. 
This phenomenon can be detected by using the technique of "light-scattering” 
that consists in the ray of light dispersion when it crosses the mitochondrial 
suspension. If matrix volume is increased, it can be observed a decrease of 
dispersion and, consequently, a decrease also of absorbance.  
RLM (1mg/ml) were incubated in standard medium for about 15 minutes in the 
different experimental conditions. Swelling was monitored using an UV/VIS 
KONTRON UVIKON 922 spectrophotometer, at 540 nm of wavelength. 
Assay for evaluating the release of cyt. c, Smac/DIABLO 
and AIF 
Samples (1mg prot/ml) were incubated in the various experimental conditions, in 
standard medium, for about 15 minutes at 20°C and were then centrifuged at 
14000 rpm for 2 minutes with Centrifuge 5415C. The supernatant fraction 
(containing the pro-apoptotic factors) was concentrated with the PAGEprepTM 
Protein Clean-Up and Enrichment Kit (PIERCE). Concentrated samples were 
then incubated at 100°C for 4 minutes and loaded on SDS-page gel. 
SDS-polyacrilamide gel electrophoresis (SDS-Page) is one of the main methods 
used for the qualitative analysis of protein mixtures and it is based on the 
separation of proteins according to size. Sodium dodecil sulfate (SDS) is an 
anionic detergent that, binding to proteins, provokes their denaturation. Thus, 
each protein is fully denatured and carries on a series of negatively charged SDS 
molecules along the polypeptide chain because, on overage, each SDS molecule 
binds to every two amino acids residues. During the electrophoretic process SDS-
protein complexes migrate, under the effect of the electric field, towards the 
anode.  
SDS-polyacrylamide gels were prepared following the method of Laemmli [1970]. 
In every experiment presented, in order to determine the molecular weight of the 
proteins and also to identify the proteins of interest, molecular weight standards 
were used. 
The electrophoretic plate is composed of two types of gel: 
1. Stacking gel (pH 6.8) has the function to concentrate protein samples 
2. Running gel (pH 8.8) in which the real separation of protein takes place 
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Polyacrilamide gels are usually defined in terms of the total percentage of 
acrylamide present. For cyt. c and Smac/DIABLO determination, a gel of 15% 
acrylamide has been used while for AIF detection a gel of 10% acrylamide has 
been chosen. 
The electrophoretic plate (8x10cm) was fixed in a dedicated device (Mighty Small 
SE 250, Hoefer Scientific Instruments). The electrophoresis duration was 
approximately 1.5 hours with an electrical current of 35 mA/gel.  
At the end of the electrophoretic process, the pattern of separated protein has to 
be transferred or blotted from the gel to a sheet of nitrocellulose paper. The 
transfer is achieved using a proper buffer (25 mM Tris, 192 mM glycine and 20% 
methanol, pH 8) and applying a current of 100 mA for 2 hours (for cyt. c and 
Smac/DIABLO) and 350 mA for 50 minutes (for AIF). 
After blotting, membrane was saturated for 30 minutes, under constant shaking, 
with a saturation buffer containing  TBS 1X and 3% BSA. TBS 1X was diluted 
from an initial buffer (TBS 20X) composed as follows: 1 M Tris/HCl and 3 M NaCl 
(pH 7.5). 
The membrane was then incubated over-night at 4°C with an appropriate 
antibody diluted in a buffer containing TBS 1X and 0.1% Tween. 
Mouse monoclonal antibody anti-cytochrome c was purchased from Pharmingen, 
rabbit polyclonal antibody anti-Smac/DIABLO and rabbit polyclonal antibody anti-
AIF from Millipore. 
After the binding between the first antibody and the protein of interest, three 
washes of about 10 minutes each were performed, at room temperature, with the 
washing buffer (TBS 1X and 0.1% Tween). Then the membrane was incubated, 
under constant shaking, with the second antibody (PerkinElmer), obtained 
against the animal species immunized for the first antibody and diluted in the 
washing buffer. Again three washes of 10 minutes each were performed and then 
the membrane was ready for antibody detection. The system adopted was 
enhanced chemiluminescence (ECL) where the reagents, in contact with the 
membrane, give rise to a reaction of chemiluminescence in correspondence to 
the position of antigene-antibody complexes, detected by autoradiography.  
In this study the Amersham ECL Prime Western Blotting Detection Reagent kit 
was adopted.  
Densitometry was performed on scanned Western Blot images using the ImageJ 
gel analysis tool [Abramoff et al., 2004]. The gel analysis tool was settled in order 
to consider the mean gray value, the min and max gray value and the area of 
each experimental band. The overall brightness and contrast of every whole 
image was optimized for the densitometric analysis, without modifying the 
information present in it, according to Rossner and Yamada [2004]. Results were 
expressed are percentages and normalized against the background.  
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Assay for evaluating the presence/activation of Bax 
RLM (5mg/ml) were incubated in standard medium, in the various experimental 
conditions, for about 15 minutes at 20°C. This mitochondrial concentration was 
chosen in order to compare these results with the other Western Blot reported in 
which, as previously described, the supernatant was concentrated with a specific 
kit. After incubation and centrifugation (14000 rpm for 2 minutes with Centrifuge 
5415C), mitochondrial pellets (P) and supernatants (S), derived from different 
mitochondrial preparations (1st, 2nd, 3rd, 4th), were analyzed by SDS-Page and 
Western Blot, as described in the previous section for cyt. c and Smac/DIABLO. 
To detect Bax presence and Bax activation, a rabbit polyclonal antibody anti-Bax 
(N-terminous) and a mouse monoclonal antibody anti-Bax (6A7), respectively, 
from Santa Crutz, were used.  
 
Fluorimetric assay to hydrogen peroxide determination 
The H2O2 produced by mitochondria was measured by scopoletin (6-metoxy-7-
idroxy-1,2-benzopirone) method [Loschen et al., 1971]. Mitochondria (0,5 mg/ml) 
were incubated in the standard medium in presence of 2 M scopoletin and 10 
M horseradish peroxidase (HRP), at 20°C. 
The HRP, in presence of H2O2, oxidizes scopoletin that loses its fluorescence, 
with the following reaction: 
 
The fluorescence was measured utilizing a SHIMADZU RF-5000 
spectrofluorimeter, with 350 nm of excitation wavelength and 460 nm of emission 
wavelength. 
The amount of H2O2 produced by mitochondria wass calculated, from the values 
obtained, by using a calibration curve obtained with H2O2. 
 
Uptake of agmatine in mitochondria 
Mitochondria (1mg/ml) were incubated in the standard medium in presence of 
radio-labeled agmatine (50 Ci/mmol), at 20°C. AGM accumulation by RLM was 
determined with the centrifugation-filtration method on gradient, as previously 
described [Toninello et al., 1985], with the utilization of plastic test tubes for 
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micro-centrifuge Eppendorf 5414. In the test tubes 0.15 ml of saccarose 12.5% 
(w/v) with ρ= 1.08 were added and, upper, 0.40 ml of a silicon oil mixture with 
ρ=1.05 (AR 100/AR 150 (2:1) Walker-Chemie Gmbh, Munich). At different times 
0.5 ml of each sample were collected, placed in the tubes on the layer of silicon 
oil, and centrifuged at 14000 g for 1 minute.  
During centrifugation, mitochondria crossed the layer of silicon oil and leaved 
sediment in sucrose. Supernatant was drawn and tube walls were washed two 
times with bidistilled water. Then, the layer of silicon oil was also drawn, leaving 
only the sucrose layer. Tubes were shaken with vortex in order to detach the 
mitochondrial pellet from the walls and 0.85 ml of solubilizing buffer (1 mM EDTA, 
0.1% NaCl, 0.9% Sodium deoxycholate) were added.  
Finally, the solubilized pellet was transferred in mini Poly-Q vials were 3 ml of 
scintillation liquid (Ultima Gold) were added and radioactivity was determined by 
using a Beckman counter LS-1800. 
Thermodynamic analyses of ligand-receptor interactions 
Binding parameters were obtained by applying thermodynamic treatment of 
ligand-receptor interactions [Di Noto et al., 1996; 2002]. For the simulation of 
agmatine binding (B) as a function of the free agmatine amount in solution (F), it 
was applyed the following equation, characteristic of a system with two binding 
sites: 
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The binding constants and the consequent energies of interaction were 
determined using Eq [6] for Scatchard analyses and Eq [7] for Hill analyses. 
These equations were both obtained from the same general equation [Di Noto et 
al., 1996; 2002] and their rationale considers receptors with different groups of 
binding sites (s) where each one could have multiple coordination (ni). The 
subsequent algebric elaborations were previously developed [Dalla Via et al., 
1996]. 
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where  
      ∑
[ ]   
∏        
 
   
  
     
 
represents the appropriate measure of the extent of multiple coordination on the 
i-th sites. [Bmax,i] is the maximum concentration of ligand that may be bound to the 
i-th sites, [Bi] is the concentration of ligand bound to the i-th sites, [Bmax] is the 
maximum receptor-bound ligand concentration and [B] is the concentration bound 
to the receptor. [F] is the free ligand concentration, Ki, j(t) is the affinity constant of 
the ligand for the i-th site, j is the occupancy number, and t is the time. Fitting was 
performed using a home written package of Igor procedures working in the Igor 
Pro ver. 6.0.4.0 of WaveMetrix Inc. (Oregon, USA, 2007). The fits were 
performed by using the Igor minimization subroutines which are called from the 
main package.  
The distribution of total bound agmatine on its binding sites was calculated by the 
parameter Xi(F). This parameter is the mole fraction of the i-th site that may 
bound to the receptor and has been calculated by means of Eq. [8]. 
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                                                    [ ]                                                     [9] 
where βi is a parameter that describes the influence of the parallel filling of the 
other k-th sites in comparison to filling of the i-th site. 
AGM binding energy and the Hill factor were calculated substituting s=2 and ni=1 
in Eqs. [6] and [7] and by considering t=0, thus obtaining the following equations: 
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Part I  
Agmatine action on the permeabilization  
of mitochondrial membranes 
 
 
Bivalent effect of agmatine on the MPT 
It has been shown that AGM exerts several effects on (isolated) mitochondria, 
revealing close relationships between this amine and the organelle functions [for 
a review see Agostinelli et al., 2010]. As detailed in the Introduction, AGM shows 
opposite effects, acting as an amplifier or an inhibitor of the MPT, depending on 
the concentration: at low concentrations (10-100 μM) AGM produces H2O2 and 
induces the MPTP opening by oxidative stress; at high concentrations (1 mM), 
although it still generates large amounts of H2O2, AGM self-scavenging effect 
prevents alterations of the redox state and other bioenergetics parameters of 
mitochondria [Battaglia et al., 2007].  
This dichotomic effect has been the issue of the first part of the thesis. Due to the 
strong correlation between MPT and the release of pro-apoptotic factors, it was 
studied whether the above opposite effects could be further confirmed by the 
release/retention of the main pro-apoptotic proteins.  
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Results 
Effect of agmatine on pro-apoptotic factors release 
Mitochondria incubated in standard medium and in presence of high Ca2+ 
concentrations, undergo the induction of MPT that, as above emphasized, is 
evidenced by the colloid-osmotic swelling of the organelles. This phenomenon is 
evaluated by monitoring the decrease of apparent absorbance of the 
mitochondrial suspension at 540 nm. 
 
Fig. 8 Effect of agmatine on mitochondrial swelling induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. Where present: Ca
2+
 and AGM at the concentrations indicated at side of 
the traces. Downward deflections indicate mitochondrial swelling. Assays performed five 
times gave almost identical results.  
 
Fig. 8 shows the above mentioned bivalent effect of different concentrations of 
AGM on mitochondrial swelling induced by Ca2+. In particular, it is well evidenced 
the double effect: 10 μM and 100 μM AGM (traces 3 and 4, respectively) are able 
to amplify the effect of Ca2+ alone (trace 2), whereas 1mM AGM (trace 5) shows 
an inhibitory activity. AGM alone (trace 6), at all the concentrations tested, is 
comparable to the control (trace 1). These results clearly demonstrate a 
protective effect of 1mM AGM on the mitochondrial swelling and an inductive 
effect at low concentrations.  
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A        1        2           3              4      5         6           7               8 
 
Ca
2+
 - 60 M 60 M 60 M 60 M    
AGM - - 10 M 100 M 1 mM 10 M 100 M 1 mM 
B 
 
Fig. 9 Release of cytochrome c induced by agmatine in presence of Ca2+ (A) 
and densitometric analysis (B). RLM (1mg/ml) were incubated in standard medium 
under the same conditions as in Fig. 8 and the supernatant fraction was analyzed by 
SDS-Page and Western Blot, as described in Material and methods section. Assays 
performed four times gave almost identical results. The values reported in Fig. 9B are 
expressed as percentage.  
 
Fig. 9A reports the result of the Western Blot conducted on the mitochondrial 
supernatant fractions, showing the release of cyt. c. In Fig. 9B a densitometric 
output is shown. It is clear that 10 and 100 µM AGM, in the presence of Ca2+ 
(lanes 3 and 4, respectively), causes a considerable loss of the protein, about 
16% and 26% higher if compared to the control (lane 1), thus confirming the pro-
apoptotic effect of the amine. A similar output, although with a lesser extent, is 
observable also with Ca2+ alone (lane 2, 15%), observation in agreement with 
Ca2+ induction of MPT. Taking into account the MPT-inhibitory effect of 1 mM 
AGM shown in Fig. 8, the result reported in lane 5 is unexpected. As observable, 
the pattern of release present in lane 5 (38%) is higher than that present in lanes 
2, 3 and 4 (15%, 16%, and 26%, respectively). Thus, cyt. c seems to be released 
also through a different process, probably MPT-independent. 
  
1 2 3 4 5 6 7 8
0 
14.908 15.857 
26.240 
38.455 
0 0 4.540 
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A        1        2             3   4       5               6             7    8 
 
Ca
2+
 - 60 M 60 M 60 M 60 M    
AGM - - 10 M 100 M 1 mM 10 M 100 M 1 mM 
B
 
 
Fig. 10 Release of AIF induced by agmatine in presence of Ca2+ (A) and 
densitometric analysis (B). RLM (1mg/ml) were incubated in standard medium under 
the same conditions as in Fig. 8 and the supernatant fraction was analyzed by SDS-Page 
and Western Blot, as described in Material and methods section. Assays performed four 
times gave almost identical results. The values reported in Fig. 10B are expressed as 
percentage.  
 
A different scenario is observable analyzing the release of AIF (showed in Fig. 
10A), which is induced only by Ca2+ alone (lane 2, 22%) or in the presence of low 
AGM concentrations (lanes 3 and 4, 20% and 25%, respectively). The release of 
AIF in the presence of Ca2+ and 1mM AGM is considerably lower (lane 5, about 
14%). The same consideration can be made if the effects of AGM alone at all the 
concentrations (lanes 6-8, 7%, 5% and 2%, respectively) are compared to the 
control (lane 1, 5%). This result is in agreement with the induction of 
mitochondrial swelling showed in Fig. 8. 
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As described in the Introduction, the intra-mitochondrial localization of these 
proteins is different: while cyt. c is an intermembrane space protein, AIF is a 
transmembrane protein of the IM. Thus, in order to evaluate if the localization of 
the proteins is important for explaining the obtained results, a third pro-apoptotic 
factor was analyzed, Smac/DIABLO, which is present in the intermembrane 
space. 
 
A         1        2             3   4       5               6             7       8 
 
Ca
2+
 - 60 M 60 M 60 M 60 M - - - 
AGM - - 10 M 100 M 1 mM 10 M 100 M 1 mM 
B 
 
Fig. 11 Release of Smac/DIABLO induced by agmatine in presence of Ca2+ 
(A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium under the same conditions as in Fig. 8 and the supernatant fraction was 
analyzed by SDS-Page and Western Blot, as described in Material and methods section. 
Assays performed four times gave almost identical results. The values reported in Fig. 
11B are expressed as percentage.  
 
The output shown in Fig. 11 resembles the release of cyt. c (Fig. 9A): 10 and 100 
µM AGM, in the presence of Ca2+ (lanes 3 and 4), cause a considerable loss of 
the protein (29% and 27%, respectively), about thirty times higher if compared to 
the control (lane 1, 0%) and to Ca2+ alone (lane 2, 3%), and the presence of 1mM 
AGM further enhances its release (lane 5, 36%). This output indicates that 
Smac/DIABLO and cyt. c (both intermembrane space proteins) could exit from 
mitochondria utilizing the same pathway, suggesting also that the mitochondrial 
localization of the factors is important in AGM-induced release. Moreover, the 
observed release of cyt. c and Smac/DIABLO happens without mitochondrial 
swelling, as demonstrated by the experiment reported in Fig 8, thus in the 
absence of MPT induction.  
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MPT-independence 
The MPT phenomenon has been widely studied over the past years and several 
inductors and inhibitors have been identified. One of the most well-known 
inhibitors is the immuno-suppressive drug cyclosporin A (CsA). This compound 
binds to CypD, which is one of the candidate components for the MPTP complex. 
In fact, as reported by Leung and Halestrap [2008], MPTP opening involves a 
conformational change in a membrane protein that is facilitated by the binding of 
CypD. This modification can occur also in the absence of CypD, but higher Ca2+ 
concentrations are needed, supporting at least a MPT-regulatory action for CypD. 
Thus, CsA binding to CypD results in MPT prevention [Halestrap et al., 1997; 
Halestrap, 2009]. 
In order to evaluate the possible MPT-independence of the differential release of 
pro-apoptotic factors induced by AGM, experiments with CsA were performed, as 
observable in Figs. 12-13. 
 
Fig. 12 Effect of agmatine and cyclosporin A on mitochondrial swelling 
induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, AGM and CsA are at the concentrations indicated 
at side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
In Fig. 12 it is reported the protecting effect exhibited by 1 mM AGM (trace 3) 
against the swelling induced by Ca2+ (trace 2). The addition of CsA (trace 4), as 
expected, further enhances AGM action.  
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Fig. 13 Release of cytochrome c and Smac/DIABLO induced by agmatine in 
presence of Ca2+ and cyclosporin A (A) and densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium under the same conditions as in Fig. 
12 and the supernatant fraction was analyzed by SDS-Page and Western Blot, as 
described in Material and methods section. Assays performed four times gave almost 
identical results. The values reported in Fig. 13B are expressed as percentage.  
 
The correspondent Western Blot conducted on the mitochondrial supernatant 
fractions is shown in Fig. 13A. With regard to the release of cyt. c, it is clear the 
almost total prevention exhibited by CsA (lane 4, 9%) with respect to the effect of 
AGM plus Ca2+ (lane 3, 50%). A similar output is evidenced also for the release of 
Smac/DIABLO. CsA, even if with less extent, exhibits a partial prevention (lane 4, 
28%) on the synergic effect shown by AGM plus Ca2+ (lane 3, 39%). 
With regard to these results, some considerations can be made: first of all, the 
release of the above mentioned factors occurs in the absence of swelling and 
thus without MPT induction. Also, the MPT inhibitor CsA does exhibit a partial 
prevention, suggesting that its effect could have another explanation. 
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Possible involvement of Bax 
 
In healthy cells, Bax is mostly cytosolic, although small pools have been localized 
in mitochondria, loosely attached to the OM or even membrane-inserted [Renault 
and Manon, 2011; Westphal et al., 2011]. The translocation of this pro-apoptotic 
protein, as described above, is one of the initial steps to induce MOMP, but it is 
not sufficient itself. Thus, a subsequent signal is required for the activation 
(oligomerization and pore formation) of Bax. Moreover, Costantini and 
collaborators [2000] reported that Bax-induced membrane permeabilization is 
inhibited by CsA. 
 
These previous observations raised the interest to assess whether Bax is 
involved in AGM-induced permeabilization. For this purpose, first of all, an 
experiment was performed in order to detect the presence of the protein in the 
mitochondrial preparations. 
 
 
 
Fig 14. Bax presence in the mitochondrial pellet and supernatant fractions.  
RLM (5mg/ml) were incubated in standard medium, as described in Material and methods 
section. Mitochondrial pellets (P) and supernatants (S), derived from different 
mitochondrial preparations (1
st
, 2
nd
, 3
rd
, 4
th
), were analyzed by SDS-Page and Western 
Blot. Assays performed four times gave almost identical results. 
 
The presence of Bax in different mitochondrial preparations is evidenced in Fig. 
14. A 20 kDa band is evident, indicating that the protein is clearly localized in 
every pellet portion (P), whereas the supernatant fraction does not show any 
signal. Mitochondria have not been treated with MPT/MOMP inducers and thus it 
is reasonable to think that the protein could be anchored to the OM, but probably 
not active (pro-apoptotic). 
  
 P      S     P      S      P     S          P    S 
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During apoptosis both Bax and Bak undergo conformational changes and the use 
of an anti-Bax conformation-specific antibody (6A7) allows to detect the presence 
of the protein, upon an apoptotic signal [Westphal et al., 2011]. 
 
A 
                            1                 2        3             4 
 
Ca
2+
 - 60 M 60 M 60 M 
AGM - - 1 mM 1 mM 
CsA - - - 1 M 
B 
 
Fig. 15 Presence of activated Bax in the mitochondrial pellet fraction (A) 
and densitometric analysis (B). 
RLM (5mg/ml) were incubated in standard medium and analyzed by SDS-Page and 
Western Blot, as described in Material and methods section. Assays performed four times 
gave almost identical results. The values reported in Fig. 15B are expressed as 
percentage.  
 
In Fig. 15A it is represented the result of the Western Blot conducted on the 
mitochondrial pellet fraction: a stronger activation of the protein in the presence of 
Ca2+ plus AGM is evidenced (lane 3, 36%), comparing with that in the presence 
of Ca2+ alone (lane 2, 24%). The addition of CsA considerably decreases the 
signal (lane 4, 16%). These data support the involvement of Bax in AGM action. 
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Possible involvement of the Voltage-Dependent Anion Channel  
 
VDAC, besides being one of the most abundant proteins of the OM, exhibits a 
preponderant role in regulating metabolite fluxes across this membrane. As 
concerning the MOMP model, the involvement of different proteins is under study 
and several models demonstrate that Bax could directly interact with VDAC, 
resulting in pore openings formation. Moreover, VDAC alone is indispensable for 
ROS-induced cyt. c release in a MPT-independent pathway [Kumarswamy and 
Chandna, 2009]. Taking into account these observations, the effect of a powerful 
VDAC inhibitor, Ruthenium Red (RR) [Israelson et al., 2008], was tested, as 
reported in Figs. 16-17. 
 
 
Fig. 16 Effect of agmatine and Ruthenium Red on mitochondrial swelling 
induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, AGM and RR at the concentrations indicated at 
side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
Fig. 16 shows that the swelling induced by Ca2+ (trace 2) is prevented by the 
addition of 1mM AGM (trace 3). The presence of RR (trace 4) further enhances 
the above mentioned inhibition.  
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Fig. 17 Release of cytochrome c and Smac/DIABLO induced by agmatine in 
presence of Ca2+ and Ruthenium Red (A) and densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium under the same conditions as in Fig. 
16 and the supernatant fraction was analyzed by SDS-Page and Western Blot, as 
described in Material and methods section. Ruthenium Red (RR) was added at different 
times: from the beginning (t=0), after 2 minutes (t=2) and after 5 minutes of incubation 
(t=5). Assays performed four times gave almost identical results. The values reported in 
Fig. 17B are expressed as percentage.  
The data showed in Fig. 17A clearly evidence that the release of cyt. c induced 
by AGM (lane 3, 29%) is strongly decreased by the addition of RR from the first 
minute of incubation (t=0) (lane 4, 8%). The effect of RR diminishes by increasing 
the time of incubation: as evidenced, it is less effective after 2 minutes of 
incubation (lane 5,17%) and even less powerful after 5 minutes of incubation 
(lane 6, 21%). Smac/DIABLO release, instead, seems to be unaffected by the 
addition of RR at any time of incubation (lanes 4, 5 and 6, respectively 23%, 
21%, and 18%) if compared to AGM alone (lane 3, 19%). As previously 
described, in mitochondria the presence of different pools of cyt. c has been 
detected. Given that 1mM AGM does not alter mitochondrial bioenergetics 
parameters, it is reasonable to think that the pool of cyt. c released is probably 
the loosly attached one, not involved in the electron transport chain. Thus, its 
mechanism of release will be almost immediate, as supported by our data, and 
for this reason RR was added at different times of incubation.  
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Discussion 
As apparent from the preceding section, the study focused on the correlation 
between AGM and intrinsic apoptosis following AGM dichotomic effect on the 
MPT.  
The importance of mitochondria in the apoptotic process, through at least three 
main mechanisms, is nowadays well-recognized: disruption of the electron 
transport chain with the consequent impairment of ATP synthesis; release of 
proteins able to trigger caspase activation; alteration of the cellular redox 
potential [Green and Reed, 1998]. In these scenarios, MPT represents a key 
step, whose induction alters the permeability of the organelle, allowing the 
release of pro-apoptotic proteins [van Gurp et al., 2003]. 
I have presented data supporting AGM double effects on the induction of the 
MPT triggered by Ca2+ (Fig. 8), suggesting that AGM acts as a typical MPT 
inducer, or inhibitor, depending on the concentrations used (low concentrations, 
in the range of 10-100 µM, and high concentration, 1mM). The activity of an 
inducer or inhibitor of MPT is usually linked to the release and retention of pro-
apoptotic proteins, respectively. Thus, my observation that both cyt. c (Fig. 9) and 
Smac/DIABLO (Fig. 11), but not AIF (Fig. 10) are released in the presence of 
Ca2+ and 1 mM AGM (a condition in which the MPTP is closed and mitochondrial 
impermeability is maintained) is unforeseen.  
A possible explanation relates to the differential localization of the pro-apoptotic 
factors: cyt. c and Smac/DIABLO are intermembrane space proteins [Ott et al., 
2001; Maly, 2007], whereas AIF is a type I IM protein [Otera et al., 2005]. Thus, it 
is reasonable to hypothesize that AGM could trigger MOMP, a process that 
involves only the OM, and release only intermembrane space proteins (cyt. c and 
Smac/DIABLO), as observed. This could be related to other reports showing that 
several compounds, among which polyamines, exhibit a similar behavior, 
allowing the release of pro-apoptotic factors without MPT induction [Stefanelli et 
al., 2000; Yamada et al., 2009].  
That observed differential release of pro-apoptotic factors by AGM, could thus 
occur independently of the MPT. To verify this possibility the release of pro-
apoptotic proteins was further investigated in the presence of the powerful MPT 
inhibitor CsA (Figs. 12,13), with the expectation that, if only MOMP is involved, 
CsA should not inhibit the AGM-dependent release of pro-apoptotic proteins. 
Interestingly, while CsA enhanced the prevention of swelling exhibited by 1mM 
AGM (Fig. 12), it almost totally prevented also the release of cyt. c and 
Smac/DIABLO induced by AGM (Fig. 13). This latter data in clearly in 
disagreement with my previous hypothesis.  
In front of these results, another consideration has to be taken into account: the 
Bcl-2 family proteins are important regulators of apoptosis and one of the pro-
apoptotic members, Bax, is fundamental for MOMP induction. Moreover, the 
activity of this protein is inhibited by CsA, that prevents its activation and 
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translocation to mitochondria [Siu et al., 2008]. In order to shed light on AGM 
action, the possible involvement of Bax was then considered. Obtained data have 
provided evidence that Bax is present in each mitochondrial preparative and that 
it localizes in the pellet fraction (Fig. 14). Also its activation state was considered, 
given that, when inserted in the OM, a conformational change occurs, enabling 
Bax detection by a specific antibody. The reported results (Fig. 15) have indeed 
shown that a stronger activation of the protein is observable in the presence of 
both AGM and Ca2+, which is inhibited by CsA, thus supporting Bax involvement 
in AGM action.  
Several findings support that the interaction between Bax and VDAC results in 
the formation of pore openings in the OM and that the production of H2O2 causes 
the formation of channels, by interacting with membrane components and 
probably through the involvement of VDAC. It has also been suggested that Bax 
is fundamental for the release of cyt. c in a ROS-mediated and MPT-independent 
pathway [Petrosillo et al., 2003; Kumarswamy and Chandna, 2009]. These 
results acquire increasing importance in light of the observation that AGM can 
induce a dose-dependent production of H2O2 [Battaglia et al., 2007], probably 
following its oxidation by a copper-dependent amine oxidase present in matrix 
[Cardillo et al., 2009]. With this background, this work tested the involvement of 
VDAC to possibly disclose some mechanistic aspects of MOMP induction. The 
use of the VDAC inhibitor RR demonstrated that VDAC is involved in AGM-
induced cyt. c release, whereas it is not part of the route exploited by 
Smac/DIABLO (Figs. 16, 17). Although studies are clearly necessary to 
eventually identify the components of the release pathways, the data obtained so 
far allow some considerations. 
First of all, it is possible to hypothesize that, while preventing the MPT induced by 
Ca2+, AGM is able to induce the release of the pro-apoptotic factors that localize 
in the mitochondrial intermembrane space. This action is ascribable to the 
selective permeabilization of the OM of mitochondria, probably through the 
MOMP induction, for which both the production of H2O2 (caused by AGM 
oxidation into the matrix) and Bax activation play a role. 
With regard to the production of ROS, which itself seems sufficient to 
permeabilize mitochondrial membranes [Petrosillo et al., 2003], also the 
scavenging action of AGM has to be taken into account. Indeed, AGM at high 
concentrations, besides being oxidized, is also able to exhibit self-protection, as 
SPM, against the produced ROS. Thus, it is reasonable to hypothesize that the 
amount of ROS produced by the amine could be sufficient to trigger the MOMP, 
but not enough to open the MPTP. Moreover, H2O2, or other ROS derived from 
its metabolism, interacting with membrane components, can cause the formation 
of pores in the OM, probably mediated by VDAC and Bax. Cyt. c and 
Smac/DIABLO could then be released by mitochondria through these openings, 
without alterations of the IM. As mentioned before, cyt. c is one of the proteins 
involved in the intrinsic apoptotic pathway, being a component of the apoptosome 
that activate caspases and promotes cell death. However it is possible that the 
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release observed in these conditions, without MPT opening and thus in the 
absence of all the components of the intrinsic apoptotic machinery, could have a 
different physiological significance. Indeed, there are evidences supporting the 
notion that the redox state of cyt. c is fundamental for the apoptosome formation 
and the subsequent death signal cascade. Specifically, it has been reported that 
only oxidized cyt. c triggers the apoptosome [Hancock et al., 2001; Ripple et al., 
2010]. Thus, by considering that, even if cyt. c is released from mitochondria in a 
oxidized state, it can be rapidly reduced by other factors, such as glutathione, the 
possibility exists that cyt. c does not trigger apoptosis under these conditions. 
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Part II  
Analyzing agmatine action by using 
its analog -methyl-agmatine 
 
ROS production by agmatine 
Battaglia and collaborators [2007] have demonstrated that AGM induces an 
oxidative stress in RLM, by producing H2O2 in a dose-dependent manner. This 
process is probably due to the oxidation of AGM by an amine oxidase whose 
activity was discovered in RLM [Cardillo et al., 2009]. To explain the inhibition of 
MPT exhibited by 1mM AGM –despite the huge amount of H2O2 produced under 
these conditions– it has been claimed that AGM at high concentrations exhibits 
antioxidant properties because the amount of AGM not yet oxidized, act as a 
ROS scavenger. This process thus results in a self-protecting event against the 
same ROS that AGM itself produces. 
-methyl-agmatine 
The second part of the thesis, that is now presented, has focused on the AGM 
analog, -methyl-agmatine (MeAGM), (kindly provided by Professor Khomutov, 
Engelhardt Institute, Moscow, Russia).  
 
Fig. 18 -methyl-agmatine. 
This compound has been designed with the aim to have a molecule unable to be 
oxidized by amine oxidases, as a methyl group in -position to amino group 
generally prevents oxidation [Khomutov AR, Personal Communication]. Thus, 
MeAGM would be a useful tool to better examine the involvement of ROS in 
AGM-dependent pro-apoptotic factors release. The investigation was carried out 
by analyzing MeAGM in the same experimental conditions employed for 
analyzing AGM behavior.  
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Results 
-methyl-agmatine uptake by RLM 
The transport of the analog in RLM is fundamental to study its activity on the 
organelles. It is possible that, being structurally similar to AGM, both compounds 
utilize the same transporter. Thus, the aim of the following experiments is to 
characterize the transport of AGM in the presence of MeAGM. It is to note that, 
unfortunately, it was not possible to measure the direct transport of MeAGM, 
due to the unavailability of the radio-labelled compound. Thus, an indirect 
measurement was done with [14C]AGM, as shown in the following figure. 
 
Fig. 19 Agmatine transport in presence of -methyl-agmatine. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
Methods section, with [
14
C]AGM (50µCi/mmol). Values are the means  SD of five 
experiments. Inset: effect of AGM and MeAGM on . 
 
AGM uptake by energized RLM, incubated in standard medium and measured 
with the radio-labeled molecule, is about 123 nmol/mg of protein after 30 minutes 
of incubation. In the presence of MeAGM, a gradual inhibition of AGM transport 
is observable, (with a decreased transport of about 33 and 26 nmol/mg of protein 
at 20 and 30 minutes, respectively). These data support the hypothesis that the 
amine and its analog use the same transporter. Considering that AGM transport 
is electrophoretic, it is also to emphasize that both AGM and MeAGM do not 
affect , as shown in the inset of Fig.19. 
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AGM uptake by energized RLM during the first 5 minutes of incubation is linear 
with time at all the concentrations tested (an example is given in the inset of Fig. 
20). This linear trend allows to extrapolate, as previously reported [Dalla Via et 
al., 1996], the different aliquots of AGM that bind to mitochondrial membranes at 
zero-time, represented in Fig. 20. 
 
 
Fig. 20 Concentration-dependent agmatine binding in presence of -methyl-
agmatine. 
RLM (1mg/ml) were incubated for 5 minutes in standard medium, as described in 
Materials and methods section, with different [
14
C]AGM concentrations in the range of 50-
2000 µM (50µCi/mmol). AGM bound at zero-time (Bo) has been plotted as a function of 
the exogenous AGM concentration [AGM]. Values are the means  SD of five 
experiments. Inset: concentration-dependent SPM uptake by RLM. 
 
In Fig. 20 it is shown that the aliquots of AGM bound at zero-time (B0) decrease 
in the presence of the analog, in particular when AGM concentration is in the 
range between 100-1500 µM.  
These parameters allow to apply the thermodynamic treatment of ligand-receptor 
interactions [Di Noto et al., 1996]. Some preliminary and qualitative information 
about the type of process examined are reported in Table 3.  
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Bmax 
(nmol/mg 
prot) 
Bmax1 
(nmol/mg 
prot) 
Bmax2 
(nmol/mg 
prot) 
K1,1 
(mg 
prot/nmol) 
K2,1 
(mg 
prot/nmol) 
β1 
(mg 
prot/nmol) 
AGM 120.22(4) 0.047(2) 120.17(2) 4.9(1)x10-2 4.15(3)x10-4 93(4) 
AGM + 
MeAGM 
120(1) 0.01(3) 119.99(4) 2.0(1)x10
-2
 3.70(5)x10
-4
 200(3) 
Table 3. Agmatine binding parameters determined by curve fittings of Eqs. 
10 and 11 reported in the Materials and methods section.  
1mM MeAGM was present in the medium. 
(a) 
Standard deviations in the least significant digits are given in parentheses and were 
determined by the propagation formula on the basis of experimental and fitting error 
analyses.
 
 
 
In Table 3 the binding parameters of AGM in the absence or in the presence of 
the analog are reported. This analysis confirms the presence of two binding sites 
for AGM on mitochondrial membranes, observation in agreement with previously 
published data [Martinis et al., 2012]. With regard to AGM alone, the total binding 
concentration is 120.22 nmol/mg of protein distributed between two sites (S1 and 
S2), in the percentages of 0.04 and 99.96, respectively, as demonstrated by the 
maximum amount of AGM bound to S1 (Bmax1 = 0.047 nmol/mg of protein) and to 
S2 (Bmax2 = 120.17 nmol/mg of protein). The association constants K1,1 and K2,1 of 
S1 and S2 sites, respectively, demonstrate that S1 has a higher affinity than S2. 1 
describes the possible influence of the parallel filling of S2 on that of S1 site. This 
parameter results to be very high, indicating that AGM binding on S2 can 
influence its binding on S1. The presence of MeAGM causes a decrease of 
AGM binding on S1 of about 79% (as Bmax1 in the presence of MeAGM is 0.01 
nmol/mg of protein with respect to 0.047 nmol/mg of protein with AGM alone). 
This inhibiting effect exerted by the analog on AGM binding is not present on the 
second site S2: the total binding site concentration (Bmax), and the one referring to 
the second site (Bmax2), are almost identical and S2 influence on S1 is enhanced. 
Moreover the association constants are both decreased in the presence of 
MeAGM and, in particular, the strongest effect is observable on K1,1.  
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Production of hydrogen peroxide by-methyl-agmatine  
H202 production by AGM has already been tested, as previously described, 
showing the capacity of the amine to produce a dose-dependent amount of this 
ROS [Battaglia et al., 2007]. A comparison between AGM and MeAGM 
production of H202 is shown in Fig. 21.  
 
Fig. 21 Effect of MeAGM on H202 production. 
RLM (0.5 mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, AGM and MeAGM at the concentrations 
indicated at side of the traces. Values are the means  SD of five experiments. 
 
AGM, in the presence of Ca2+, is able to produce about 1 nmol H202/mg of protein 
(trace 2) if compared to Ca2+ alone (trace 1, about 0.3 nmol/mg of protein). In the 
same experimental conditions the presence of MeAGM (trace 3) is comparable 
to the control trace, suggesting that the analog is not able to produce significant 
amounts of H202. The same output was obtained also in the absence of Ca
2+ (data 
not shown). 
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Effect of-methyl-agmatine on pro-apoptotic factors release 
The investigation on the behavior of MeAGM, in order to compare its activity to 
AGM action, leads to the evaluation of its effect on the MPT, monitoring 
mitochondrial swelling. 
 
Fig. 22 Effect of MeAGM on mitochondrial swelling induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
 and MeAGM at the concentrations indicated at 
side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
Fig. 22 shows the effect of 1mM MeAGM on mitochondrial swelling induced by 
Ca2+. It is clear the inhibitory effect exerted by this compound (trace 3) if 
compared to Ca2+ alone (trace 2). In addition, the analog, at the concentration of 
1mM, shows a stronger effect if compared to 1mM AGM (Fig. 8, previous 
section), being able to fully protect mitochondria against the MPT induced by 
Ca2+. Thus the release of pro-apoptotic factors was analyzed, as shown in Fig. 
23. 
  
54 
 
    A                     1       2       3          4  
 
Ca
2+
 - 60 M 60 M - 
MeAGM - - 1 mM 1 mM 
    B 
 
Fig. 23 Release of cytochrome c induced by MeAGM in presence of Ca2+ 
(A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium under the same conditions as in Fig. 22 and the supernatant fraction was 
analyzed by SDS-Page and Western Blot, as described in Material and methods section. 
Assays performed four times gave almost identical results. The values reported in Fig. 
23B are expressed as percentage.  
MeAMG shows a strong effect in inducing the release of cyt. c (lane 3, 60%), as 
shown in Fig. 23A, especially if compared to Ca2+ alone (lane 2, 21%). MeAMG 
alone does not show any effect (lane 4, 0.9%). 
 
    A                     1       2             3             4  
 
Ca
2+
 - 60 M 60 M - 
MeAGM - - 1 mM 1 mM 
    B 
 
Fig. 24 Release of AIF induced by MeAGM in presence of Ca2+ (A) and 
densitometric analysis (B). RLM (1mg/ml) were incubated in standard medium under 
the same conditions as in Fig. 22 and the supernatant fraction was analyzed by SDS-
Page and Western Blot, as described in Material and methods section. Assays performed 
four times gave almost identical results. The values reported in Fig. 24B are expressed 
as percentage.  
1 2 3 4
17.898 21.315 
59.900 
0.887 
1 2 3 4
12.819 
76.827 
9.434 0.923 
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As previously observed for agmatine activity (Fig. 10, previous section), the 
release of AIF shown in Fig. 24A is observable only in the presence of Ca2+ (lane 
2, 77%) whereas the effect of the analog, in the presence of Ca2+ (lane 3, 9%) is 
comparable with the control lane (lane 1, 13%). MeAMG alone does not show 
any effect (lane 4, 0.9%). 
 
    A                     1          2              3                4  
 
Ca
2+
 - 60 M 60 M - 
MeAGM - - 1 mM 1 mM 
    B 
 
Fig. 25 Release of Smac/DIABLO induced by MeAGM in presence of Ca2+ 
(A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium under the same conditions as in Fig. 22 and the supernatant fraction was 
analyzed by SDS-Page and Western Blot, as described in Material and methods section. 
Assays performed four times gave almost identical results. The values reported in Fig. 
25B are expressed as percentage.  
 
It has to be clarified, before the description of this experiment, that the release of 
Smac/DIABLO in presence of the analog shows two different trends. The one 
described by this picture (Fig. 25A), shows that the release of Smac/DIABLO by 
Ca2+ (lane 2, 23%) is slightly decreased by MeAMG (lane 3, 17%). However, it 
is to take into account that the analog alone (lane 4, 10%) induces Smac/DIABLO 
efflux, if compared to the control line (trace 1, 5%). In several other experiments, 
instead, the presence of both Ca2+ and MeAMG exhibit a synergic effect in 
inducing its release, if compared to Ca2+ alone, (an example is given at page 59). 
One possible explanation could be that the presence of the compound, besides 
inhibiting Ca2+ action (which is also supported by the swelling experiments), acts 
itself in inducing the pro-apoptotic factors release. Thus, the outputs obtained by 
Western Blot analyses are the result of both the inhibiting effect on Ca2+ action 
and the stimulating activity on pro-apoptotic factors release.  
  
1 2 3 4
4.835 
23.138 16.880 9.814 
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MPT-independence 
As previously shown for the study of AGM behavior, the MPT-inhibitor CsA was 
tested to assess the MPT-independence of the differential release of pro-
apoptotic factors observed in the presence of MeAGM. 
 
Fig. 26 Effect of MeAGM and cyclosporin A on mitochondrial swelling 
induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, MeAGM and CsA at the concentrations indicated 
at side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
Fig. 26 shows that, as expectable, CsA does not have any effect on MeAGM 
prevention of swelling, as MeAGM alone (trace 3) is able to fully prevent the 
effect of Ca2+ (trace 2). 
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 A 
                         1              2        3        4 
  
  
 
Ca
2+
 - 60 M 60 M 60 M 
MeAGM - - 1 Mm 1 mM 
CsA - - - 1 M 
B 
 
   
Fig. 27 Release of cytochrome c and Smac/DIABLO induced by MeAGM in 
presence of Ca2+ and cyclosporin A (A) and densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium in the same conditions as in Fig. 26 
and the supernatant fraction was analyzed by SDS-Page and Western Blot, as described 
in Material and methods section. Assays performed four times gave almost identical 
results. The values reported in Fig. 27B are expressed as percentage.  
Fig. 27A shows the Western Blot conducted on the mitochondrial supernatant 
fractions, from samples obtained at the end of the incubations shown in Fig. 26. 
Concerning cyt. c, the addition of CsA totally prevents its release (lane 4, 0%) 
comparing to the effect of MeAGM plus Ca2+ (lane 3, 67%). As previously 
observed, Ca2+ is able to release the protein (lane 2, 33%) with respect to control 
(lane 1, 0%). A similar behavior of CsA is evidenced also for the release of 
Smac/DIABLO, that is prevented (lane 4, 0%) if compared to the effect shown by 
MeAGM plus Ca2+ (lane 3, 36%). These results demonstrated that MeAGM 
and its analog share the same behavior on the release of pro-apoptotic factors.  
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Possible involvement of the Voltage-Dependent Anion Channel  
 
The involvement of VDAC was also tested, by the use of its inhibitor RR, as 
described in the precedent section. 
 
 
Fig. 28 Effect of MeAGM and Ruthenium Red on mitochondrial swelling 
induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, MeAGM and RR at the concentrations indicated 
at side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
Fig. 28 shows that, as expectable, RR does not have any effect on MeAGM 
prevention of swelling, as MeAGM alone (trace 3) is able to fully prevent the 
effect of Ca2+ (trace 2). 
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Fig. 29 Release of cytochrome c and Smac/DIABLO induced by MeAGM in 
presence of Ca2+ and Ruthenium Red (A) and densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium in the same conditions as in Fig. 28 
and the supernatant fraction was analyzed by SDS-Page and Western Blot, as described 
in Material and methods section. Ruthenium Red (RR) was added at different times: from 
the beginning (t=0) and after 5 minutes of incubation (t=5). Assays performed four times 
gave almost identical results. The values reported in Fig. 29B are expressed as 
percentage.  
The data showed in Fig. 29A evidence a strong inhibition of RR, when added 
from the first minute of incubation (t=0) on the release of cyt. c (lane 4, 12%), if 
compared to the release of the protein induced by MeAGM (lane 3, 34%). RR is 
less effective if added after 5 minutes of incubation (t=5), as evidenced by the 
output of lane 4, 36%. With regard to Smac/DIABLO release, RR seems to be 
ineffective if added from the first minute of incubation (lane 4 26%, if compared to 
MeAGM-induced release (lane 3, 29%). A slight decrease is observable if RR is 
added after 5 minutes of incubation (lane 5, 17%).  
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Discussion 
As presented, the investigation on the effects of AGM on the permeabilization of 
the OM was carried out by comparing the effects of MeAGM, an AGM analog 
designed to be resistant to amine oxidases. 
This approach is justified by considering that in RLM the oxidation of AGM 
produces H2O2 in a dose-dependent manner [Battaglia et al., 2007], by the 
activity of a copper-dependent amine oxidase present in matrix [Cardillo et al., 
2009], and that moreover H2O2 is one of the strongest factors responsible for 
MOMP induction [Petrosillo et al., 2003]. 
The reported results suggest that both AGM and its analog share the same 
transport mechanism, in light of the data showing that, in the presence of 
MeAGM, both AGM transport (Fig. 19) and binding (Fig. 20) are decreased. 
Moreover, the binding parameters of AGM alone (Table 3), fully comparable with 
other published data [Martinis et al., 2012], confirm the presence of two binding 
sites (S1 and S2) on mitochondrial membranes for AGM. In the presence of 
MeAGM, a noticeable decrease of AGM bound to S1 is observable, whereas the 
amount of amine bound to S2 remains almost unaffected. The effect of MeAGM 
on S1 resembles in part the behavior of the I2 inhibitor idazoxan [Martinis et al., 
2012]. Indeed, idazoxan binding to S1 was found to decrease the amount of 
bound AGM (from 1.34 to 0.56 nmol/mg of protein), and also the correspondent 
association constant (from 4.9 x 10-2 to 2.3 x 10-2). On the other hand, whereas 
idazoxan increased the maximum amount of amine bound to S2, MeAGM had 
no effect. Considering our previous hypothesis with regard to idazoxan action, 
whereby S1 could act as a sensor of the amount of AGM present outside 
mitochondria and could thus modify the properties of S2 transport site, it is 
possible to suggest that a different mechanistic action pertains to MeAGM. 
Indeed, when idazoxan binds to S1, this site detects a lower AGM concentration, 
and this can cause a modification of the binding and transport properties of S2, to 
increase the transport of AGM. However, given the structural similarities of AGM 
and MeAGM, in the presence of the analog it could also be possible that S1 is 
unable to discriminate between the two compounds. MeAGM binding to S1 is 
therefore not achieved as a diminution of AGM concentration and consequently 
the transport properties of S2 are not modified. Although the characterization of 
the transport mechanism of the analog is not yet fully clarified, these data support 
the contention that the internalization of both compounds into the mitochondrial 
matrix, occurs exploiting the same transporter, possibility that is of value for the 
study of MeAGM effects on mitochondria. 
Presented data have clearly underlined that MeAGM binding to mitochondrial 
membranes, and its subsequent internalization, does not result in ROS 
production, because MeAGM production of H2O2 is negligible compared to the 
amounts produced in the presence of AGM (Fig. 21). This observation sets a 
difference between the behavior of these two compounds. However, MeAGM 
activity on the permeabilization of mitochondrial membranes closely resembles 
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AGM behavior, in light of the capacity of the analog to fully prevent Ca2+-induced 
MPT (Fig. 22) and to induce the release of cyt. c and Smac/DIABLO (Figs. 23, 25 
respectively), but not AIF (Fig 24), as was shown with AGM. Taken together, all 
these results seem to exclude that the production of H2O2 by AGM is key to its 
effects, thus supporting the possibility that the main mechanism driving AGM-
induced permeabilization of mitochondrial membranes is through Bax activation. 
The effects of CsA (Figs. 26 and 27) and of the VDAC inhibitor RR (Figs. 28 and 
29) were also analyzed in the presence of MeAGM. CsA fully prevented the 
release of cyt. c and Smac/DIABLO and RR inhibited the release of cyt. c, but not 
of Smac/DIABLO release.  
Obtained data show that both molecules behaved in a similar way, probably 
inducing the MOMP. 
 
 
 
 
63 
 
Part III  
Polyamines action on the permeabilization  
of mitochondrial membranes 
  
Effect of polyamines on the MPT 
Polyamines are related to AGM, given that both have arginine as precursor 
amino acid (Fig. 30). Moreover polyamine metabolism is regulated by AGM 
because the amine induces antizyme that leads to the inactivation of ornithine 
decarboxylase and the suppression of polyamine transport [Piletz et al., 2013]. 
 
Fig. 30 Arginine is the precursor of both polyamines and agmatine 
biosynthesis. 
 
In mitochondria, polyamines exhibit a protective effect against the MPT [Tassani 
et al., 1995], similar to that observed with 1 mM AGM [Battaglia et al., 2007]. The 
aim of the following study was thus to evaluate polyamine action on the release 
of pro-apoptotic factors and to make a comparison with the effects of AGM.  
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Results 
Effect of polyamines on pro-apoptotic factors release 
The evaluation of the effect of polyamines on the MPT is carried out by 
monitoring mitochondrial swelling. 
 
Fig. 31 Effect of polyamines on mitochondrial swelling induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, SPM, SPD, PUT and Mg
2+
 at the concentrations 
indicated at side of the traces. Downward deflections indicate mitochondrial swelling. 
Assays performed five times gave almost identical results.  
 
The swelling experiment showed in Fig. 31 clearly demonstrates that all the 
polyamines (traces 3, 4 and 5) are able to prevent the effect exhibited by Ca2+ 
(trace 2). SPM demonstrates the most powerful action (trace 3) if compared to 
SPD (trace 4), and PUT (trace 5), which is the less effective. Thus the following 
experiments were made with the aim of investigate the release of pro-apoptotic 
factors, in the presence of all the polyamines. 
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       A        1          2         3            4          5 
 
Ca
2+
 60 μM - + + + + 
SPM 100 μM - - + - - 
SPD 100 μM - - - + - 
PUT 100 μM - - - - + 
       B 
  
Fig. 32 Release of cytochrome c induced by polyamines in presence of Ca2+ 
(A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium in the same conditions as in Fig. 31 and the supernatant fraction was analyzed 
by SDS-Page and Western Blot, as described in Material and methods section. Assays 
performed four times gave almost identical results. The values reported in Fig. 32B are 
expressed as percentage.  
 
Fig. 32A shows the Western Blot analyses conducted on the mitochondrial 
supernatant fraction. First of all, it clearly shows that Ca2+ alone (lane 2) or in the 
presence of polyamines (lanes 3, 4, 5), is able to release cyt. c, if compared to 
the control (lane 1). However, it is to underline that none of the polyamines show 
a synergic effect with Ca2+ (observed, instead, with AGM, Results presented in 
Part I, Figs. 9, 11). Indeed SPM-, SPD-, and PUT-induced release (lanes 3, 22%; 
4, 28% and 5, 22%) does not differ considerably from Ca2+ one (trace 2, 25%). 
This can be explained by considering the inhibiting effect shown by these 
compounds on Ca2+ action (which is also supported by the swelling experiments). 
Thus, the outputs obtained are the result of both the inhibiting effect on Ca2+ 
action and the stimulating activity on pro-apoptotic factors release exhibited by 
polyamines. Probably the release observed is due only to the action of 
polyamines, rather than a sum of their action and Ca2+ effect. Very preliminary 
data support this hypothesis, showing that the polyamines alone, in particular 
SPM, are able to release some pro-apoptotic factors in the absence of Ca2+ (an 
example is given in the following figure). 
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       A                1   2        3          4      
 
Ca
2+
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       B 
 
 
Fig. 33 Release of cytochrome c induced by spermine in presence of Ca2+ 
(A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium and analyzed by SDS-Page and Western Blot, as described in Material and 
methods section. Preliminary data. The values reported in Fig. 33B are expressed as 
percentage.  
The preliminary experiment presented in Fig. 33 shows the induced release of 
cyt. c in the presence of Ca2+ alone (lane 2, 28%) or with SPM (lane 3, 33%). The 
presence of SPM alone causes a noticeable release (lane 4, 24%). 
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Fig. 34 Release of AIF induced by polyamines in presence of Ca2+ (A) and 
densitometric analysis (B). RLM (1mg/ml) were incubated in standard medium under 
the same conditions as in Fig. 31 and analyzed by SDS-Page and Western Blot, as 
described in Material and methods section. Assays performed four times gave almost 
identical results. The values reported in Fig. 34B are expressed as percentage.  
A strong release of AIF, shown in Fig. 34A, is observable only in the presence of 
Ca2+ (lane 2, 27%), whereas both SPM and SPD lanes in the presence of Ca2+ 
(lanes 3, 8% and 4, 7%) are comparable with the control lane (lane 1, 7%). A 
slight release is observable with PUT (lane 5, 17%) and it can be explained by 
considering that this polyamine is not able to fully prevent the MPT (Fig. 31). 
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Fig. 35 Release of Smac/DIABLO induced by polyamines in presence of 
Ca2+ (A) and densitometric analysis (B). RLM (1mg/ml) were incubated in standard 
medium in the same conditions as in Fig. 31 and the supernatant fraction was analyzed 
by SDS-Page and Western Blot, as described in Material and methods section. Assays 
performed four times gave almost identical results. The values reported in Fig. 35B are 
expressed as percentage.  
 
The release of Smac/DIABLO presented in Fig. 35A evidences that Ca2+ effect 
(lane 2, 15%) is increased by SPM (lane 3, 28%), SPD (lane 4, 31%) and PUT 
(lane 5, 21%).  
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MPT-independence 
As showed in the previous sections, to assess that the differential release of pro-
apoptotic factors is independent from MPT, the MPT inhibitor CsA was tested. By 
taking into account that the interpretations of the results of PUT could be 
compromised by its not complete prevention against the MPT, only SPM and 
SPD were considered. 
 
Fig. 36 Effect of spermine, spermidine and cyclosporin A on mitochondrial 
swelling induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, SPM, SPD and CsA at the concentrations 
indicated at side of the traces. Downward deflections indicate mitochondrial swelling. 
Assays performed five times gave almost identical results.  
 
Fig. 36 shows that, as expectable, CsA (trace 5) does not have any effect on 
SPM (trace 3) and SPD (trace 4) prevention of swelling, as these compounds 
alone are already able to fully prevent the effect of Ca2+ (trace 2). 
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        A 
                  1          2             3     4                5             6 
  
   
 
Ca
2+ 
60 M - + + + + + 
SPM 100 mM - - + + - - 
SPD 100 mM - - - - + + 
CsA 1 M - - - + - + 
       B 
 
 
 
Fig. 37 Release of cytochrome c and Smac/DIABLO induced by spermine 
and spermidine in presence of Ca2+ and cyclosporin A (A) and 
densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium in the same conditions as in Fig. 36 
and the supernatant fraction was analyzed by SDS-Page and Western Blot, as described 
in Material and methods section. Assays performed four times gave almost identical 
results. The values reported in Fig. 37B are expressed as percentage.  
In Fig. 37A, with regard to cyt. c release, it is shown that the presence of Ca2+ 
induces a considerable loss of the protein from mitochondria (lane 2, 17%) if 
compared to the control (lane 1, 4%). The presence of both Ca2+ and SPM (lane 
3, 20%) does not enhance considerably Ca2+ action (lane 2, 17%) and the 
addition of CsA does not prevent the release of the protein (lane 4, 19%). 
Moreover, SPD (lane 5, 19%) neither enhances Ca2+ action (lane 2, 17%) nor is 
inhibited by the addition of CsA (lane 6, 21%). Concerning the release of 
Smac/DIABLO induced by SPM (lane 3, 15%), the addition of CsA does not 
prevent its release (lane 4, 16%). The same output is observable also for SPD 
action, in which the addition of CsA (lane 6, 16%) does not alter its activity (lane 
5, 15%).  
 
1 2 3 4 5 6
3.961 
17.356 20.155 18.929 18.831 20.768 
Cyt. c 
1 2 3 4 5 6
3.046 
11.270 14.975 
16.002 14.792 16.458 
Smac/DIABLO 
         Cyt. c 
 
        Smac/DIABLO 
 
 
 
71 
 
Possible involvement of the Voltage-Dependent Anion Channel  
 
In light of these different effects of polyamines, with respect to AGM, the 
involvement of VDAC was also tested, by the use of its inhibitor RR. 
 
 
Fig. 38 Effect of polyamines and Ruthenium Red on mitochondrial swelling 
induced by Ca2+. 
RLM (1mg/ml) were incubated in standard medium, as described in Materials and 
methods section. When present: Ca
2+
, SPM, SPD and RR at the concentrations indicated 
at side of the traces. Downward deflections indicate mitochondrial swelling. Assays 
performed five times gave almost identical results.  
 
Fig. 38 shows that, as expectable, RR (trace 5) does not have evaluable effects 
on SPM (trace 3) and SPD (trace 4) prevention of swelling, as polyamines alone 
fully prevent the effect of Ca2+(trace 2). 
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       A                   1            2          3          4        5         6           7          8 
   
 
Ca
2+ 
60 M - + + + + + + + 
SPM 100 M - - + + + - - - 
SPD 100 M - - - - - + + + 
RR 1 M - - - + 
(t=0) 
+ 
(t=5) 
- + 
(t=0) 
+ 
(t=5) 
       B
 
 
Fig. 39 Release of cytochrome c and Smac/DIABLO induced by MeAGM in 
presence of Ca2+ and Ruthenium Red (A) and densitometric analysis (B). 
RLM (1mg/ml) were incubated in standard medium in the same conditions as in Fig. 38 
and the supernatant fraction was analyzed by SDS-Page and Western Blot, as described 
in Material and methods section. Ruthenium Red (RR) was added at different times: from 
the beginning (t=0) and after five minutes of incubation (t=5). Assays performed four 
times gave almost identical results. The values reported in Fig. 39B are expressed as 
percentage.  
Results shown in Fig. 39A evidence a strong inhibition of RR, when added from 
the first minute of incubation (t=0) on the release of cyt. c induced by SPM and 
SPD (lanes 4, 8% and 7, 0.4%, respectively), if compared to the release of the 
protein induced by the compounds (lanes 3, 22% and 6, 22%, respectively). RR 
is less effective in inhibiting cyt. c release induced by SPM, if added after 5 
minutes of incubation (t=5), as evidenced by the output of lane 5 (25%), whereas 
a strong inhibition is observed on SPD induced release (lane 8, 3%) even in this 
incubating conditions. With regard to Smac/DIABLO release, RR seems to be 
ineffective on SPM effect, when added from the first minute of incubation (lane 4, 
9%) or after 5 minutes (lane 5, 9%), if compared to the polyamine-induced 
release (lane 3, 8%). A negligible effect on SPD-induced release (lane 6, 6%) is 
observable if RR is added at both times of incubation (lanes 7, 4% and 8, 4%).  
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Discussion 
According to the notion that polyamines and AGM show similar structural and 
activity features, the previous section evaluated the behavior of polyamines under 
the same conditions used for both AGM and MeAGM study.  
Among the variety of effects ascribable to polyamines action in mitochondria [for 
a review see Toninello et al., 2004], MPT is undoubtedly one main target, which 
is strictly related to the release of pro-apoptotic proteins from mitochondria. 
Polyamines are generally considered inhibitors of the MPT (SPM is one of the 
most powerful physiological ones) [Toninello et al., 1984; Tassani et al., 1995] 
and, indeed, results presented in the previous section support this aspect (Fig 
31). However, the Western Blot analyses on mitochondrial supernatant fractions 
(Figs. 32, 34, 35) have also shown the release of both cyt. c and Smac/DIABLO, 
but not of AIF, in the presence of Ca2+ and polyamines. At difference from the 
synergic effect exhibited by Ca2+ and AGM (Figs. 9 and 11, respectively, Part I), 
polyamines and Ca2+ together release as much pro-apoptotic factors as Ca2+ 
alone. A possible explanation, as above emphasized, should take into account 
the inhibiting effect shown by polyamines on Ca2+-induced MPT. Polyamines, in 
particular SPM, while inhibiting the induction of MPT by Ca2+, are able to 
stimulate themselves the release of pro-apoptotic factors, thus not resulting in a 
synergic effect with Ca2+. Indeed, preliminary data (Fig. 33) show that SPM alone 
(in the absence of Ca2+) is able to release the pro-apoptotic factors, thus 
supporting this hypothesis. 
It has to be underlined that the latter effect exerted by polyamines alone is not 
very surprising considering that they also stimulate the uptake of phosphate 
[Toninello et al., 1984], which, together with Ca2+, is one of the main MPT 
inducers. It thus seems that polyamines, while enhancing its uptake, are also 
able to exert a protective effect on mitochondrial swelling and it is possible that 
the combination of the protective and toxic effects of polyamine results in MOMP, 
but not in MPT induction.  
Another difference between AGM and polyamines relates to the action of CsA. As 
expected, CsA does not modify the inhibition of swelling exerted by SPM and 
SPD (which fully prevent the MPT) (Fig. 36), but it cannot inhibit the release of 
cyt. c and Smac/DIABLO induced by these polyamines in the presence of Ca2+ 
(Fig. 37). These results demonstrate the MPT-independence of the observed 
phenomenon and also suggest that the mechanism of action of polyamines is 
different from that of AGM. 
In cells, polyamines are also a source of cytotoxic metabolites and, as reported 
by Agostinelli and collaborators [2004], the oxidative deamination of polyamines 
by amine oxidase (i.e., monoamine oxidases, diamine oxidases, polyamine 
oxidases and copper-containing amine oxidases) generates H2O2 and 
aldehyde(s). It is therefore possible that, at the cellular level, the damaging action 
of polyamines is ascribable to their oxidation products. However, having Cardillo 
and collaborators [2009] detected also in mitochondria the activity of a copper-
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dependent amine oxidase (capable to oxidize polyamines and diamines), one 
can speculate that the small amount of ROS produced by polyamine oxidation 
could be sufficient to trigger the MOMP. Indeed, as previously underlined, it has 
been observed a ROS-mediated and MPT-independent release of cyt. c and that 
the ROS-induced permeabilization of the OM is likely to be mediated by VDAC 
[Petrosillo et al., 2003; Kumarswamy and Chandna, 2009]. For this reason, the 
involvement of VDAC was tested (Fig. 38-39), and the obtained results showed 
that, as already observed for AGM, VDAC is probably involved in the pathway of 
release of cyt. c, excluding, at the same time, its role in Smac/DIABLO release. 
 
These data further highlight that AGM, although related to polyamines, displays 
typical features. A further confirmation arises from data obtained by the use of 
liposomes carrying electrostatically attached cyt. c, where the only variable is the 
electric charge [Stefanelli C, Department of Pharmacy and Biotechnology, 
University of Bologna, Personal Communication]. In this study, AGM (divalent) 
potential in inducing the release of cyt. c is lower than that of SPM (tetravalent) 
and SPD (trivalent). This is in contrast with the experiments presented in the 
previous sections where AGM action in releasing cyt. c is higher than polyamines 
one.  
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Part IV  
Polyamines efflux from mitochondria 
  
Polyamines cycling in mitochondria 
The mechanism of influx of polyamines have been characterized in RLM 
[Toninello et al., 1992a; 1992b], but there is a lack of knowledge about their efflux 
pathway. Indeed, despite the presence of several previous studies [Toninello et 
al., 1985; 1986; 1988], this pathway is far from being completely understood. It is 
reasonable to think that a cycling-mechanism, similar to Ca2+ one, could be a 
crucial point in order to explain the previous shown observed effects. 
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Results 
Spermine efflux 
SPM is accumulated in RLM by an electrophoretic mechanism, dependent on a 
high transmembrane potential [Toninello et al., 1985]. Thus the addition of 
uncouplers is able to cause the efflux of the polyamine, a mechanism that could 
account for deenergizing, or even pathological, conditions. However, in a more 
physiological environment, due to the importance of maintaining an equilibrium in 
the polyamine content, another pathway it feasible, able to operate with a high 
membrane potential. 
 
Fig. 40 Spermine uptake by RLM in the presence of adenine nucleotides. 
Mitochondria were incubated in standard medium supplemented with [
14
C]SPM 
50Ci/mmol. Values are the means  SD of four experiments. Inset: effect of SPM and 
ADP (incubated under the same conditions as in Fig. 40) on . 
 
Fig. 40 shows that the amount of SPM transported by RLM (trace 1) is 
consistently decreased by the presence of both ADP (trace 2) or ATP (trace 3) in 
the medium of incubation. Trace 4 also evidences that a considerable efflux of 
SPM is observable, if ADP is added after 21 minutes. Thus the efflux of SPM 
seems to be linked to the presence of these adenine nucleotides. However, it has 
to be admitted that the addition of ADP causes a slight decrease of , due to 
the fact that a portion of the electrochemical gradient is used to synthesize ATP 
and this effect is shown also in the presence of SPM (Inset, trace 4).  
Thus an objection could be that SPM efflux is caused by this decrease.  
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Membrane potential-independence 
In order to exclude that the decrease of  is responsible for the above observed 
SPM efflux, the effects of nigericin (Fig. 41) and mersalyl (Fig. 42) were tested. 
The first is a ionophore that induces an exchange of endogenous K+ with 
exogenous H+, leading to a complete collapse of pH and a consequent 
argument of  to the maximum value of 220 mV [Graven et al., 1966]. Mersalyl, 
instead, is an inhibitor of phosphate transport and, as a consequence, its addition 
causes also a decrease of  [Tyler, 1968].
 
Fig. 41 Spermine uptake by RLM in the presence of ADP and/or nigericin. 
Mitochondria were incubated in standard medium supplemented with [
14
C]SPM 
50Ci/mmol. Values are the means  SD of four experiments. Inset: effect of SPM, ADP, 
and nigericin (incubated under the same conditions as in Fig. 41) on . 
 
SPM transport (trace 1) is increased in the presence of nigericin (trace 2), as a 
result of  enhancement (Inset, trace 2). The addition of ADP in the same 
experimental condition decreases the rate of entrance of SPM (trace 3), 
suggesting that even with the maintenance of a high , a SPM efflux pathway is 
operating. Indeed, in these conditions, as shown in the inset, the decrease of  
caused by oxidative phosphorylation is negligible. It is to note that, in this 
experimental condition, the addition of ADP at the 15th minute of incubation, 
instead of the 21st as the other experiments, is made with the purpose to better 
appreciate the effect.   
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Fig. 42 Spermine uptake by RLM in the presence of mersalyl and/or adenine 
nucleotides and/or nigericin. Mitochondria were incubated in standard medium 
supplemented with [
14
C]SPM 50Ci/mmol.
 
Values are the means  SD of four 
experiments. Inset: effect of SPM, mersalyl, nigericin, and adenine nucleotides, 
(incubated under the same conditions as in Fig. 42) on . 
 
The experiment represented in Fig. 42 further support the previous findings. The 
presence of mersalyl in the medium of incubation excludes the possibility of ATP 
formation, as the uptake of phosphate is blocked. This condition causes also the 
decrease of  (Inset, trace 2), as previously described, and thus SPM transport 
is lowered. The subsequent addition of nigericin (11th minute) increases SPM 
transport, as expected, due to the enhancement of  caused by the ionophore. 
Finally, the addition of both ADP and ATP (21st minute), causes SPM efflux.  
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Correlation with adenine nucleotide translocator 
The hypothesized correlation between SPM efflux and the fluxes of ADP and 
ATP was further studied by the use of the ATP-synthase inhibitor oligomycin (Fig. 
43) and the AdNT inhibitor bongkrekic acid (BKA) (Fig. 44). 
 
Fig. 43 Spermine uptake by RLM in the presence of ADP and/or oligomycin. 
Mitochondria were incubated in standard medium supplemented with [
14
C]SPM 
50Ci/mmol. Values are the means  SD of four experiments. 
 
In Fig. 43 the effect of oligomycin is shown. Trace 2 represents the efflux of SPM 
after the addition of ADP (21st minute). If oligomycin is present in the medium, the 
subsequent addition of ADP does not provoke any effect in the uptake of the 
polyamine. Thus, this process seems to be related to ATP synthesis or ADP/ATP 
exchange. The involvement of the adenine nucleotide translocator was 
investigated by the use of BKA, as shown by Fig. 44. 
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Fig. 44 Spermine uptake by RLM in the presence of adenine nucleotides 
and/or BKA. Mitochondria were incubated in standard medium supplemented with 
[
14
C]SPM 50Ci/mmol. Values are the means  SD of four experiments. 
 
SPM transport as a control is represented by trace 1. As evidenced by trace 2, if 
BKA is added after 15 minutes, SPM accumulation is not affected, as well as 
after the addition of ADP (21st minute). A possible explanation is that even if ATP 
is endogenously synthesized, it cannot exit from mitochondria because of BKA 
block on the translocator. In these conditions SPM continues to accumulate. A 
different output is observable by adding first ADP (15th minute), causing SPM exit 
from mitochondria, and then BKA (21st minute), that clearly inhibits its efflux, 
restoring SPM uptake (trace 3). These data suggest that SPM, ADP and ATP 
fluxes are linked. 
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Discussion 
The issue of polyamine cycling across mitochondrial membranes was 
investigated in this paragraph.  
As described in the Introduction, polyamines exhibit a large number of functions 
in cells as well as in mitochondria. The requirement of a polyamine transporter is 
legitimized by the fact that high quantities of these compounds have been found 
in mitochondria, even if the organelles do not possess a biosynthetic pathway. 
Moreover, their activity in preventing or inducing apoptosis, is dependent on their 
concentration, modulated also by the proposed mitochondrial cycling. 
Unfortunately, despite the presence of several previous studies their efflux 
pathway is not completely characterized [Toninello et al., 1985; 1986; 1988]. As 
Toninello and collaborators demonstrated [1985], deenergized mitochondria by 
the addition of uncouplers or electron transport chain inhibitors, release SPM. In 
this conditions the driving force able to transport and retain in matrix the 
polyamine, , is collapsed, by which it has been proposed that SPM exits in 
exchange with protons, reuptaken by the collapse of the electrochemical 
gradient. This mechanism of efflux could account for deenergizing, or even 
pathological, conditions, but a different case, maybe operating in physiological 
environments, is considered in this section.  
I have presented data supporting the involvement of the AdNT in the mechanism 
of efflux of SPM. First of all, the presence of either ADP or ATP in the medium 
considerably decreased the amount of SPM transported by mitochondria. 
Moreover, the addition of ADP after 21st minutes of incubation, when a 
substantial quantity of the polyamine was internalized, caused an evident efflux 
of SPM (Fig. 40). During ATP synthesis, a slight decrease of  is observable, 
due to the fact that a portion of the electrochemical gradient is used to synthesize 
ATP. Being SPM transport electrophoretic, an objection could be that the 
decrease of  causes SPM efflux. However, the decrease observed is unlikely 
involved in SPM efflux because of its extent (of about 10 mV), whichmaintains 
membrane potential in a physiological condition.  
Moreover, the use of nigericin, a ionophore able to increase at its maximum 
level, (Fig. 41) seems to exclude again the possibility of a mere effect on . The 
inset of Fig. 41 shows that the decrease of caused by ADP additionis 
minimized in the presence of nigericin, whereas the rate of influx of the polyamine 
is decreased even with the addition of nigericin, supporting the presence of an 
efflux pathway, which balances the influx.  
A further confirmation is demonstrated in the concomitant presence of mersalyl 
(inhibitor of phosphate transporter) and nigericin (Fig. 42), where the addition of 
both ATP and ADP, with the consequent exchange of ADP/ATP across the 
membrane, induced SPM efflux, suggesting that, in this case, the process is not 
driven by a decrease in . In this experimental conditions both the nucleotides 
are necessarily added, because the presence of phosphate in the matrix is at 
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minimum (due to mersalyl action) by which ATP is not synthesized. These data 
exclude the involvement of the decrease of in SPM efflux and arise the 
hypothesis about the correlation between the fluxes of SPM and the adenine 
nucleotides. 
At this point, the investigation better analyzed this hypothesis by the use of the 
H+-ATP-synthase inhibitor, oligomycin, and the adenine nucleotide translocator 
inhibitor, BKA (Figs. 43 and 44, respectively). Oligomycin and BKA fully 
prevented SPM outflow, supporting the correlation between SPM effluxes and 
ADP/ATP exchange.  
Taking into account all these data, some considerations can be made. First of all, 
as it is well-known, the ATP/ADP exchange is electrogenic, with a net efflux of a 
negative charge. Moreover, the tetravalent SPM, by interacting with the alkaline 
matrix, is most probably partially deprotonated, by which it is supposable that 
SPM carries three positive charges. It is also to consider that during SPM efflux 
also phosphate is released, as supported by a recent paper of our group 
[Grancara et al., 2013]. Indeed, as we suggested, in the presence of both SPM 
and mersalyl (blocker of phosphate uptake), the efflux of phosphate is observed, 
suggesting a new pathway or a change in the carrier function for its efflux. Thus, 
it is possible to propose an electroneutral efflux of SPM during ATP/ADP 
exchange, in parallel with the efflux of phosphate, as a bivalent anion.  
The efflux pathway of SPM, at present, is yet unknown as it cannot utilize the 
uptake transporter [Toninello et al., 1992a]. However, the direct involvement of 
the AdNT in this process, also if it seems too speculative, is not to be completely 
discarded. In fact, the function of the AdNT, according to Brustovetsky and 
Klingenberg [1996] can change from a specific channel for ADP/ATP exchange, 
to a large unselective channel. This possibility could take place also in the 
presence of SPM. It has been previously reported that SPM is able to interact 
with some proteins such as just the AdNT [Krämer et al., 1986], ATP synthase 
[Solaini and Tadolini, 1984], and phosphate carrier [Toninello et al., 1986], by 
modifying their activity and/or function. Finally, all these proteins, due to the 
above mentioned changes and considering the observed effects of oligomycin, 
BKA and mersalyl, may be involved in SPM efflux. Experiments are in progress in 
our laboratory for obtaining results to further support this hypothesis. 
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Conclusions 
The work carried out for my PhD thesis focused primarily on the action of 
biologically active amines –agmatine and polyamines, such as spermine and 
spermidine– on isolated mitochondria. Accumulated data allow to draw the 
following conclusions. 
(I) Both agmatine and polyamines are able to induce the release of 
mitochondrial pro-apoptotic factors, such as cyt. c and Smac/DIABLO, 
but not AIF. 
 
(II) All tested amines can also induce MOMP, the likely responsible for cyt. c 
and Smac/DIABLO release from the intermembrane space, but not of 
AIF, a protein integral to the IM.  
 
(III) The action of agmatine and polyamines on MOMP exploits distinct 
mechanisms: while that by polyamines appears CsA-insensitive and 
mediated by ROS, agmatine action is CsA-sensitive and probably Bax-
dependent.  
 
(IV) VDAC was found to be part of the efflux pathway of cyt. c, but not of the 
route exploited by SMAC/DIABLO.  
 
(V) Spermine efflux from mitochondria is linked to the fluxes of ADP/ATP and 
phosphate, supporting the presence of a cycling mechanism for 
polyamines in mitochondria. 
In conclusion, MOMP could thus be regarded as a phenomenon linked to both 
intrinsic and extrinsic apoptosis, given that it is mediated by extra- (Bcl-2 family 
proteins) and intra-mitochondrial signals (polyamines and ROS). In this view, 
biologically active amines represent a useful tool to delineate the structural and 
functional features of  both MOMP and MPT.  
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